484 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Demjaha A, Galderisi S, Glenthøj B, Arango C, Mucci A, Lawrence A, O'Daly O, Kempton M, Ciufolini S, Baandrup L, Ebdrup BH, Rodriguez-Jimenez R, Diaz-Marsa M, Díaz-Caneja CM, Winter van Rossum I, ... Kahn R, et al. Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study. Psychological Medicine. 1-9. PMID 35197142 DOI: 10.1017/S0033291722000010  0.306
2021 Lehet M, Tso IF, Park S, Neggers SFW, Thompson IA, Kahn RS, Thakkar KN. Altered Effective Connectivity within an Oculomotor Control Network in Unaffected Relatives of Individuals with Schizophrenia. Brain Sciences. 11. PMID 34573248 DOI: 10.3390/brainsci11091228  0.316
2020 de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Alonso-Lana S, Bearden CE, Bertolino A, Bonvino A, Bramon E, Buimer EEL, Cahn W, Canales-Rodríguez EJ, Cannon DM, Cannon TD, Caseras X, ... ... Kahn RS, et al. Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder. Human Brain Mapping. PMID 33027543 DOI: 10.1002/hbm.25206  0.494
2020 Ormel PR, Böttcher C, Gigase FAJ, Missall RD, van Zuiden W, Fernández Zapata MC, Ilhan D, de Goeij M, Udine E, Sommer IEC, Priller J, Raj T, Kahn RS, Hol EM, de Witte LD. A characterization of the molecular phenotype and inflammatory response of schizophrenia patient-derived microglia-like cells. Brain, Behavior, and Immunity. PMID 32798663 DOI: 10.1016/J.Bbi.2020.08.012  0.374
2020 Correll CU, Newcomer JW, Silverman B, DiPetrillo L, Graham C, Jiang Y, Du Y, Simmons A, Hopkinson C, McDonnell D, Kahn RS. Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study. The American Journal of Psychiatry. appiajp202019121279. PMID 32791894 DOI: 10.1176/Appi.Ajp.2020.19121279  0.353
2020 Thygesen JH, Presman A, Harju-Seppänen J, Irizar H, Jones R, Kuchenbaecker K, Lin K, Alizadeh BZ, Austin-Zimmerman I, Bartels-Velthuis A, Bhat A, Bruggeman R, Cahn W, Calafato S, Crespo-Facorro B, ... ... Kahn R, et al. Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study. Molecular Psychiatry. PMID 32719466 DOI: 10.1038/S41380-020-0820-7  0.391
2020 Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. Cns Spectrums. 1-75. PMID 32594935 DOI: 10.1017/S1092852920001546  0.332
2020 Troudet R, Ali WBH, Bacq-Daian D, Rossum IWV, Boland-Auge A, Battail C, Barau C, Rujescu D, McGuire P, Kahn RS, Deleuze JF, Leboyer M, Jamain S. Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32450569 DOI: 10.1038/S41386-020-0703-2  0.305
2020 Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, ... Kahn RS, et al. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial. Psychiatry Research. 289: 112970. PMID 32438207 DOI: 10.1016/J.Psychres.2020.112970  0.316
2020 Bucci P, Mucci A, van Rossum IW, Aiello C, Arango C, Baandrup L, Buchanan RW, Dazzan P, Demjaha A, Díaz-Caneja CM, Giordano GM, Glenthøj BY, Leucht S, McGuire P, Rodriguez-Jimenez R, ... ... Kahn RS, et al. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32291210 DOI: 10.1016/J.Euroneuro.2020.03.010  0.328
2020 Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, Lind PA, Pizzagalli F, Ching CRK, McMahon MAB, Shatokhina N, Zsembik LCP, Thomopoulos SI, Zhu AH, Strike LT, ... ... Kahn RS, et al. The genetic architecture of the human cerebral cortex. Science (New York, N.Y.). 367. PMID 32193296 DOI: 10.1126/Science.Aay6690  0.545
2020 Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, Busatto GF, et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain : a Journal of Neurology. PMID 32103250 DOI: 10.1093/Brain/Awaa025  0.344
2020 van Leeuwen JMC, Vinkers CH, Vink M, Kahn RS, Joëls M, Hermans EJ. Disrupted upregulation of salience network connectivity during acute stress in siblings of schizophrenia patients. Psychological Medicine. 1-11. PMID 31941558 DOI: 10.1017/S0033291719004033  0.735
2020 Zwarte SMCd, Brouwer RRM, Kahn RS, Turner JA, Erp TGMv, Andreasen OA, Ching CRK, Jahanshad N, Thompson PM, Haren NV, Relatives E. M166. The Effect Of Intelligence And Educational Attainment On The Brain In Those With Familial High Risk For Schizophrenia Or Bipolar Disorder: An Enigma–Relatives Study Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.478  0.355
2020 Lehet M, Yao B, Tso IF, Kahn RS, Neggers SF, Thakkar KN. Compromised Neural Circuit Dynamics Underlying Impaired Control of Eye Movements in Schizophrenia Biological Psychiatry. 87: S375-S376. DOI: 10.1016/J.Biopsych.2020.02.961  0.327
2020 Chand G, Wolf DH, Erus G, Srinivasan D, Dwyer DB, Pomponio R, Sotiras A, Varol E, Doshi J, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Neuroanatomical Dimensional Phenotypes of Schizophrenia: Expression in Youth With Psychosis-Spectrum Symptoms and Correlation With Cognition Biological Psychiatry. 87: S119. DOI: 10.1016/J.Biopsych.2020.02.324  0.352
2020 van Leeuwen J, Vinkers C, Vink M, Kahn R, Joels M, Hermans E. Neural Temporal Dynamics of Stress in At-Risk Individuals Biological Psychiatry. 87: S89-S90. DOI: 10.1016/J.Biopsych.2020.02.250  0.61
2020 Wolf D, Chand G, Dwyer D, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Two Neuroanatomical Subtypes of Schizophrenia Defined by Multi-Site Machine Learning Biological Psychiatry. 87: S28-S29. DOI: 10.1016/J.Biopsych.2020.02.097  0.314
2019 Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, Gaspar H, Ikeda M, Benyamin B, Brown BC, Liu R, Zhou W, Guan L, Kamatani Y, Kim SW, ... ... Kahn RS, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nature Genetics. PMID 31740837 DOI: 10.1038/S41588-019-0512-X  0.362
2019 Sneeboer MAM, van Mierlo HC, Stotijn E, MacIntyre DJ, Smith C, Kahn RS, Hol EM, de Witte LD. Increased number of T-lymphocytes in post-mortem brain tissue of patients with schizophrenia. Schizophrenia Research. PMID 31676171 DOI: 10.1016/J.Schres.2019.10.032  0.362
2019 Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, ... ... Kahn RS, et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. PMID 31636452 DOI: 10.1038/S41588-019-0511-Y  0.538
2019 van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Reward-Related Striatal Responses Following Stress in Healthy Individuals and Patients With Bipolar Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471186 DOI: 10.1016/J.Bpsc.2019.06.014  0.729
2019 de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Aleman A, Alpert KI, Bearden CE, Bertolino A, Bois C, Bonvino A, Bramon E, Buimer EEL, Cahn W, Cannon DM, Cannon TD, ... ... Kahn RS, et al. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder. Biological Psychiatry. PMID 31443932 DOI: 10.1016/J.Biopsych.2019.03.985  0.567
2019 de Lange SC, Scholtens LH, van den Berg LH, Boks MP, Bozzali M, Cahn W, Dannlowski U, Durston S, Geuze E, van Haren NEM, Hillegers MHJ, Koch K, Jurado MÁ, Mancini M, ... ... Kahn RS, et al. Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders. Nature Human Behaviour. PMID 31384023 DOI: 10.1038/S41562-019-0659-6  0.312
2019 Berdenis van Berlekom A, Muflihah CH, Snijders GJLJ, MacGillavry HD, Middeldorp J, Hol EM, Kahn RS, de Witte LD. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies. Schizophrenia Bulletin. PMID 31192350 DOI: 10.1093/Schbul/Sbz060  0.317
2019 Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, ... ... Kahn RS, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics. PMID 31043756 DOI: 10.1038/S41588-019-0397-8  0.301
2019 Bossong MG, van Hell HH, Schubart CD, van Saane W, Iseger TA, Jager G, van Osch MJP, Jansma JM, Kahn RS, Boks MP, Ramsey NF. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30975584 DOI: 10.1016/J.Euroneuro.2019.03.010  0.538
2019 Cui LB, Wei Y, Xi YB, Griffa A, De Lange SC, Kahn RS, Yin H, Van den Heuvel MP. Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia. Schizophrenia Bulletin. PMID 30926985 DOI: 10.1093/Schbul/Sbz014  0.414
2019 Chang X, Collin G, Mandl RCW, Cahn W, Kahn RS. Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings. Neuroimage. Clinical. 101656. PMID 30660663 DOI: 10.1016/J.Nicl.2019.101656  0.422
2019 Yao B, Neggers SFW, Rolfs M, Rösler L, Thompson IA, Hopman HJ, Ghermezi L, Kahn RS, Thakkar KN. Structural thalamo-frontal hypoconnectivity is related to oculomotor corollary discharge dysfunction in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30630882 DOI: 10.1523/Jneurosci.1473-18.2019  0.361
2019 Ori A, Loohuis LO, Guintivano J, Clair DS, McQuillin A, Mill J, Sullivan P, Kahn R, Horvath S, Ophoff R. 30 Schizophrenia Is Characterized By Age- And Sex-Specific Effects On Epigenetic Aging European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.07.171  0.33
2019 Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Gur RC, Gur RE, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Busatto GF, Facorro BC, Pantelis C, et al. T195. Neuroanatomical Heterogeneity of Schizophrenia Quantified via Semi-Supervised Machine Learning Reveals Two Distinct Subtypes: Results From the PHENOM Consortium Biological Psychiatry. 85: S205-S206. DOI: 10.1016/J.Biopsych.2019.03.518  0.318
2019 Zwarte Sd, Brouwer R, Ching C, Andreassen O, Erp Tv, Turner J, Thompson P, Kahn R, Haren Nv. 21. ENIGMA-Relatives: The Association Between Familial Risk for Schizophrenia or Bipolar Disorder and Brain Abnormalities Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.035  0.384
2018 de Zwarte SMC, Brouwer RM, Tsouli A, Cahn W, Hillegers MHJ, Hulshoff Pol HE, Kahn RS, van Haren NEM. Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia. Schizophrenia Bulletin. PMID 30597053 DOI: 10.1093/Schbul/Sby182  0.409
2018 Prikken M, van der Weiden A, Baalbergen H, Hillegers MH, Kahn RS, Aarts H, van Haren NE. Spontaneous low-frequency fluctuations in the neural system for emotional perception in major psychiatric disorders: amplitude similarities and differences across frequency bands Journal of Psychiatry & Neuroscience : Jpn. 44: 1-8. PMID 30525317 DOI: 10.1503/Jpn.180049  0.348
2018 Zhang JP, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, Crespo-Facorro B, Vazquez-Bourgon J, Kane JM, Malhotra AK, Lencz T. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. The American Journal of Psychiatry. appiajp201817121363. PMID 30392411 DOI: 10.1176/Appi.Ajp.2018.17121363  0.375
2018 van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Increased responses of the reward circuitry to positive task feedback following acute stress in healthy controls but not in siblings of schizophrenia patients. Neuroimage. PMID 30243958 DOI: 10.1016/J.Neuroimage.2018.09.051  0.653
2018 Boks MP, Houtepen LC, Xu Z, He Y, Ursini G, Maihofer AX, Rajarajan P, Yu Q, Xu H, Wu Y, Wang S, Shi JP, Hulshoff Pol HE, Strengman E, Rutten BPF, ... ... Kahn RS, et al. Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia. Npj Schizophrenia. 4: 16. PMID 30131491 DOI: 10.1038/S41537-018-0058-4  0.338
2018 Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, et al. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. The Lancet. Psychiatry. PMID 30115598 DOI: 10.1016/S2215-0366(18)30252-9  0.377
2018 Fiksinski AM, Breetvelt EJ, Lee YJ, Boot E, Butcher N, Palmer L, Chow EWC, Kahn RS, Vorstman JAS, Bassett AS. Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia. Psychological Medicine. 1-8. PMID 30064532 DOI: 10.1017/S0033291718001824  0.371
2018 Schür RR, van Leeuwen JMC, Houtepen LC, Joëls M, Kahn RS, Boks MP, Vinkers CH. Glucocorticoid receptor exon 1 methylation and the cortisol stress response in health and disease. Psychoneuroendocrinology. 97: 182-189. PMID 30036796 DOI: 10.1016/J.Psyneuen.2018.07.018  0.576
2018 Bilderbeck AC, Penninx BWJH, Arango C, van der Wee N, Kahn R, Winter-van Rossum I, Hayen A, Kas MJ, Post A, Dawson GR. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neuroscience and Biobehavioral Reviews. PMID 29940238 DOI: 10.1016/J.Neubiorev.2018.06.019  0.577
2018 Egerton A, Broberg BV, Van Haren N, Merritt K, Barker GJ, Lythgoe DJ, Perez-Iglesias R, Baandrup L, Düring SW, Sendt KV, Stone JM, Rostrup E, Sommer IE, Glenthøj B, Kahn RS, et al. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre H-MRS study (OPTiMiSE). Molecular Psychiatry. PMID 29880882 DOI: 10.1038/S41380-018-0082-9  0.376
2018 Vorstman JAS, Olde Loohuis LM, Kahn RS, Ophoff RA. Double Hits in Schizophrenia. Human Molecular Genetics. PMID 29767709 DOI: 10.1093/Hmg/Ddy175  0.358
2018 Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, Yang HT, Wu T, Boks MP, Lomen-Hoerth C, Wiedau-Pazos M, Cantor RM, de Vos WM, Kahn RS, Eskin E, Ophoff RA. Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. Translational Psychiatry. 8: 96. PMID 29743478 DOI: 10.1038/S41398-018-0107-9  0.385
2018 van Leeuwen JMC, Vink M, Fernández G, Hermans EJ, Joëls M, Kahn RS, Vinkers CH. At-risk individuals display altered brain activity following stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29483659 DOI: 10.1038/S41386-018-0026-8  0.673
2018 Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD. Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients. Schizophrenia Research. PMID 29478863 DOI: 10.1016/J.Schres.2018.02.012  0.355
2018 van Haren N, Nikita S, Koevoets M, Baalbergen H, Vink M, Mesman E, Kahn R, Hillegers M. F17. DIFFERENCES IN INTRACRANIAL VOLUME, IQ AND PSYCHOPATHOLOGY IN YOUNG OFFSPRING OF PATIENTS AFFECTED WITH SCHIZOPHRENIA OR BIPOLAR DISORDER Schizophrenia Bulletin. 44: S225-S225. DOI: 10.1093/Schbul/Sby017.548  0.677
2018 Boks M, Houtepen L, Xu Z, He Y, Ursini G, Maihofer A, Rajarajan P, Hulshoff Pol H, Rutten B, Jaffe AE, Kleinmann JE, Baker D, Hol E, Akbarian S, Nievergelt C, ... ... Kahn R, et al. O4.1. GENETIC VULNERABILITY TO DUSP22 PROMOTOR HYPERMETHYLATION IS INVOLVED IN THE RELATION BETWEEN IN UTERO FAMINE EXPOSURE AND SCHIZOPHRENIA Schizophrenia Bulletin. 44: S82-S82. DOI: 10.1093/Schbul/Sby015.207  0.349
2018 Dazzan P, Reinders AS, Shatzi V, Carletti F, Arango C, Fleischhacker W, Galderisi S, Mucci A, Glenthoj B, Egerton A, Barker G, Leucht S, Meyer-Lindenberg A, Kahn RS, Rujescu D, et al. 31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS Schizophrenia Bulletin. 44: S50-S51. DOI: 10.1093/Schbul/Sby014.129  0.331
2018 van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. F228. Functional Activation Abnormalities Following Stress in At-Risk Individuals Biological Psychiatry. 83: S327. DOI: 10.1016/J.Biopsych.2018.02.842  0.619
2018 de Zwarte S, Brouwer R, Tsouli A, Cahn W, Hillegers M, Pol HH, Kahn R, van Haren N. F221. Brain Abnormalities and Cognitive Deficits in First-Degree Relatives of Patients With Schizophrenia Biological Psychiatry. 83: S325. DOI: 10.1016/J.Biopsych.2018.02.835  0.384
2018 Fiksinski A, Breetvelt E, Vorstman J, Lee E, Boot E, Butcher N, Palmer L, Chow E, Kahn R, Bassett A. F207. Neurocognition and Adaptive Functioning in the 22q11.2 Deletion Syndrome Model of Schizophrenia Biological Psychiatry. 83: S319. DOI: 10.1016/J.Biopsych.2018.02.821  0.321
2017 Blakey R, Ranlund S, Zartaloudi E, Cahn W, Calafato S, Colizzi M, Crespo-Facorro B, Daniel C, Díez-Revuelta Á, Di Forti M, Iyegbe C, Jablensky A, Jones R, Hall MH, ... Kahn R, et al. Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 1-20. PMID 29094675 DOI: 10.1017/S0033291717002860  0.303
2017 Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, ... ... Kahn RS, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. PMID 29038599 DOI: 10.1038/Mp.2017.170  0.425
2017 Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, ... Kahn RS, et al. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophrenia Research. PMID 28982554 DOI: 10.1016/J.Schres.2017.09.024  0.374
2017 Marsman A, Mandl RCW, Klomp DWJ, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. Intelligence and Brain Efficiency: Investigating the Association between Working Memory Performance, Glutamate, and GABA. Frontiers in Psychiatry. 8: 154. PMID 28966597 DOI: 10.3389/Fpsyt.2017.00154  0.301
2017 van Mierlo HC, Wichers CGK, He Y, Sneeboer MAM, Radstake TRDJ, Kahn RS, Broen JCA, de Witte LD. Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia. Journal of Psychiatric Research. 95: 231-234. PMID 28910708 DOI: 10.1016/J.Jpsychires.2017.09.006  0.395
2017 Collin G, Scholtens LH, Kahn RS, Hillegers MHJ, van den Heuvel MP. Affected Anatomical Rich Club and Structural-Functional Coupling in Young Offspring of Schizophrenia and Bipolar Disorder Patients. Biological Psychiatry. PMID 28734460 DOI: 10.1016/J.Biopsych.2017.06.013  0.377
2017 Witt SH, Streit F, Jungkunz M, Frank J, Awasthi S, Reinbold CS, Treutlein J, Degenhardt F, Forstner AJ, Heilmann-Heimbach S, Dietl L, Schwarze CE, Schendel D, Strohmaier J, Abdellaoui A, ... ... Kahn RS, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Translational Psychiatry. 7: e1155. PMID 28632202 DOI: 10.1038/Tp.2017.115  0.322
2017 Wei Y, Collin G, Mandl RCW, Cahn W, Keunen K, Schmidt R, Kahn RS, van den Heuvel MP. Cortical magnetization transfer abnormalities and connectome dysconnectivity in schizophrenia. Schizophrenia Research. PMID 28601503 DOI: 10.1016/J.Schres.2017.05.029  0.403
2017 Brouwer RM, Panizzon MS, Glahn DC, Hibar DP, Hua X, Jahanshad N, Abramovic L, de Zubicaray GI, Franz CE, Hansell NK, Hickie IB, Koenis MMG, Martin NG, Mather KA, McMahon KL, ... ... Kahn RS, et al. Genetic influences on individual differences in longitudinal changes in global and subcortical brain volumes: Results of the ENIGMA plasticity working group. Human Brain Mapping. PMID 28580697 DOI: 10.1002/Hbm.23672  0.305
2017 Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 1-13. PMID 28545597 DOI: 10.1017/S0033291717001283  0.408
2017 Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, ... ... Kahn RS, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry. PMID 28461699 DOI: 10.1038/Mp.2017.73  0.366
2017 de With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA. More than 25 years of genetic studies of clozapine-induced agranulocytosis. The Pharmacogenomics Journal. PMID 28418011 DOI: 10.1038/Tpj.2017.6  0.642
2017 Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. PMID 28369804 DOI: 10.1111/Acps.12718  0.356
2017 Keefe RS, Kahn RS. Cognitive Decline and Disrupted Cognitive Trajectory in Schizophrenia. Jama Psychiatry. PMID 28329400 DOI: 10.1001/Jamapsychiatry.2017.0312  0.308
2017 McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications. 8: 14774. PMID 28322246 DOI: 10.1038/Ncomms14774  0.371
2017 Chang X, Collin G, Xi Y, Cui L, Scholtens LH, Sommer IE, Wang H, Yin H, Kahn RS, van den Heuvel MP. Resting-state functional connectivity in medication-naïve schizophrenia patients with and without auditory verbal hallucinations: A preliminary report. Schizophrenia Research. PMID 28130005 DOI: 10.1016/J.Schres.2017.01.024  0.405
2017 Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, ... ... Kahn RS, et al. Novel genetic loci associated with hippocampal volume. Nature Communications. 8: 13624. PMID 28098162 DOI: 10.1038/Ncomms13624  0.754
2017 Egerton A, Merritt K, McQueen G, Howes O, Demjaha A, Brugger S, Barker G, Stone J, Dazzan P, Broberg B, van Haren N, Glenthoj B, Kahn R, McGuire P. SA83. Brain Glutamate Levels and Antipsychotic Response in Schizophrenia Schizophrenia Bulletin. 43: S142-S143. DOI: 10.1093/Schbul/Sbx023.081  0.377
2017 Collin G, Hillegers M, Scholtens L, Kahn R, van den Heuvel M. 166. Affected Anatomical Rich Club Core and Structural–Functional Integration in Young Offspring of Schizophrenia and Bipolar Disorder Patients Schizophrenia Bulletin. 43: S84-S84. DOI: 10.1093/Schbul/Sbx021.224  0.379
2017 Van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. The dynamic brain response to stress is impaired in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S548. DOI: 10.1016/S0924-977X(17)31047-7  0.684
2017 Van Leeuwen J, Vink M, Joëls M, Kahn R, Vinkers C. Psychosocial stress and emotion processing in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S76. DOI: 10.1016/S0924-977X(16)31211-1  0.666
2017 Zwarte Sd, Brouwer R, Hillegers M, Cahn W, Pol HH, Kahn R, Alpert K, Wang L, Bramon E, Kane F, Murray R, Hajek T, Alda M, Roberts G, Mitchell P, et al. 278. ENIGMA-Relatives – Brain Volumes in First-Degree Relatives of Schizophrenia and Bipolar Patients Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.292  0.418
2016 Prikken M, van der Weiden A, Renes RA, Koevoets MG, Heering HD, Kahn RS, Aarts H, van Haren NE. Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk. Psychiatry Research. 250: 270-276. PMID 28189096 DOI: 10.1016/J.Psychres.2016.10.077  0.358
2016 Zorn JV, Schür RR, Boks MP, Kahn RS, Joëls M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 77: 25-36. PMID 28012291 DOI: 10.1016/J.Psyneuen.2016.11.036  0.583
2016 de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 40: 38-44. PMID 27837671 DOI: 10.1016/J.Eurpsy.2016.06.011  0.548
2016 Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, ... ... Kahn RS, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nature Neuroscience. PMID 27694991 DOI: 10.1038/Nn.4398  0.736
2016 Schür RR, Boks MP, Geuze E, Prinsen HC, Verhoeven-Duif NM, Joëls M, Kahn RS, Vermetten E, Vinkers CH. Development of psychopathology in deployed armed forces in relation to plasma GABA levels. Psychoneuroendocrinology. 73: 263-270. PMID 27566489 DOI: 10.1016/J.Psyneuen.2016.08.014  0.554
2016 Collin G, Kahn RS. Schizophrenia in the Era of Brain Complexity. The Journal of Nervous and Mental Disease. 204: 561-3. PMID 27479610 DOI: 10.1097/Nmd.0000000000000545  0.376
2016 de Leeuw M, Bohlken MM, Mandl RC, Hillegers MH, Kahn RS, Vink M. Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27440007 DOI: 10.1038/Npp.2016.130  0.692
2016 Thakkar KN, Rösler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, Kahn RS, Neggers SF. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings. Biological Psychiatry. PMID 27316853 DOI: 10.1016/J.Biopsych.2016.04.007  0.344
2016 Bootsman F, Brouwer RM, Schnack HG, Kemner SM, Hillegers MH, Sarkisyan G, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. A study of genetic and environmental contributions to structural brain changes over time in twins concordant and discordant for bipolar disorder. Journal of Psychiatric Research. 79: 116-124. PMID 27218817 DOI: 10.1016/J.Jpsychires.2016.04.011  0.361
2016 Schür RR, Draisma LW, Wijnen JP, Boks MP, Koevoets MG, Joëls M, Klomp DW, Kahn RS, Vinkers CH. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies. Human Brain Mapping. PMID 27145016 DOI: 10.1002/Hbm.23244  0.606
2016 Thakkar KN, van den Heiligenberg FM, Kahn RS, Neggers SF. Speed of saccade execution and inhibition associated with fractional anisotropy in distinct fronto-frontal and fronto-striatal white matter pathways. Human Brain Mapping. PMID 27091670 DOI: 10.1002/Hbm.23209  0.353
2016 Gifford G, Crossley N, Fusar-Poli P, Schnack HG, Kahn RS, Koutsouleris N, Cannon TD, McGuire P. Using neuroimaging to help predict the onset of psychosis. Neuroimage. PMID 27039698 DOI: 10.1016/J.Neuroimage.2016.03.075  0.464
2016 Houtepen LC, Vinkers CH, Carrillo-Roa T, Hiemstra M, van Lier PA, Meeus W, Branje S, Heim CM, Nemeroff CB, Mill J, Schalkwyk LC, Creyghton MP, Kahn RS, Joëls M, Binder EB, et al. Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans. Nature Communications. 7: 10967. PMID 26997371 DOI: 10.1038/Ncomms10967  0.56
2016 Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, et al. Altering the course of schizophrenia: progress and perspectives. Nature Reviews. Drug Discovery. PMID 26939910 DOI: 10.1038/Nrd.2016.28  0.389
2016 Kleerekooper I, van Rooij SJ, van den Wildenberg WP, de Leeuw M, Kahn RS, Vink M. The effect of aging on fronto-striatal reactive and proactive inhibitory control. Neuroimage. PMID 26899783 DOI: 10.1016/J.Neuroimage.2016.02.031  0.641
2016 Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, Haukvik UK, Hartberg CB, Doan NT, Agartz I, Dale AM, Gruber O, Krämer B, Trost S, Liberg B, ... ... Kahn RS, et al. Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry. PMID 26857596 DOI: 10.1038/Mp.2015.227  0.345
2016 Collin G, Hilligers MHJ, Scholtens LH, Kahn RS, Heuvel MPVd. Rich club organization of the connectome in children at familial high risk for schizophrenia and bipolar disorder European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31552-8  0.334
2015 de Leeuw M, Bohlken MM, Mandl RC, Kahn RS, Vink M. Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study. Npj Schizophrenia. 1: 15001. PMID 27336028 DOI: 10.1038/npjschz.2015.1  0.668
2015 Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, O'Donovan M, Correll CU, Kane JM, van Os J, Insel TR. Schizophrenia. Nature Reviews. Disease Primers. 1: 15067. PMID 27189524 DOI: 10.1038/nrdp.2015.67  0.493
2015 Renes RA, Vink M, van der Weiden A, Prikken M, Koevoets MG, Kahn RS, Aarts H, van Haren NE. Impaired frontal processing during agency inferences in schizophrenia. Psychiatry Research. PMID 26776080 DOI: 10.1016/J.Pscychresns.2015.12.006  0.695
2015 Vink M, de Leeuw M, Pouwels R, van den Munkhof HE, Kahn RS, Hillegers M. Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients. Schizophrenia Research. PMID 26631365 DOI: 10.1016/J.Schres.2015.11.018  0.693
2015 Vink M, de Leeuw M, Luykx JJ, van Eijk KR, van den Munkhof HE, van Buuren M, Kahn RS. DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients. Schizophrenia Bulletin. PMID 26598739 DOI: 10.1093/Schbul/Sbv166  0.679
2015 Bootsman F, Brouwer RM, Kemner SM, Schnack HG, van der Schot AC, Vonk R, Hillegers MH, Boomsma DI, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Contribution of genes and unique environment to cross-sectional and longitudinal measures of subcortical volumes in bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26481908 DOI: 10.1016/J.Euroneuro.2015.09.023  0.338
2015 Collin G, van den Heuvel MP, Abramovic L, Vreeker A, de Reus MA, van Haren NE, Boks MP, Ophoff RA, Kahn RS. Brain network analysis reveals affected connectome structure in bipolar I disorder. Human Brain Mapping. PMID 26454006 DOI: 10.1002/Hbm.23017  0.358
2015 Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, ... ... Kahn RS, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. PMID 26286434 DOI: 10.1093/Ije/Dyv136  0.335
2015 van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26283641 DOI: 10.1038/Mp.2015.118  0.67
2015 Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 26283640 DOI: 10.1038/Mp.2015.117  0.519
2015 Emsley R, Asmal L, Chiliza B, du Plessis S, Carr J, Kidd M, Malhotra AK, Vink M, Kahn RS. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia. Psychiatry Research. PMID 26184461 DOI: 10.1016/J.Pscychresns.2015.06.014  0.668
2015 Rösler L, Rolfs M, Van der Stigchel S, Neggers SF, Cahn W, Kahn RS, Thakkar KN. Failure to use corollary discharge to remap visual target locations is associated with psychotic symptom severity in schizophrenia. Journal of Neurophysiology. jn.00155.2015. PMID 26108951 DOI: 10.1152/Jn.00155.2015  0.311
2015 van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26033243 DOI: 10.1038/Mp.2015.63  0.669
2015 Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J. Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1158-66. PMID 26004980 DOI: 10.1016/J.Euroneuro.2015.04.003  0.359
2015 Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 808-16. PMID 25907250 DOI: 10.1016/J.Euroneuro.2015.02.012  0.385
2015 Arango C, Kapur S, Kahn RS. Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia. Schizophrenia Bulletin. 41: 546-8. PMID 25864201 DOI: 10.1093/Schbul/Sbv026  0.341
2015 Renes RA, van der Weiden A, Prikken M, Kahn RS, Aarts H, van Haren NE. Abnormalities in the experience of self-agency in schizophrenia: A replication study. Schizophrenia Research. 164: 210-3. PMID 25843918 DOI: 10.1016/J.Schres.2015.03.015  0.33
2015 Bossong MG, Mehta MA, van Berckel BN, Howes OD, Kahn RS, Stokes PR. Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology. 232: 2723-9. PMID 25801289 DOI: 10.1007/S00213-015-3915-0  0.336
2015 Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophrenia Bulletin. 41: 574-83. PMID 25800248 DOI: 10.1093/Schbul/Sbv024  0.348
2015 Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, ... ... Kahn RS, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. Jama Psychiatry. 72: 377-85. PMID 25715178 DOI: 10.1001/Jamapsychiatry.2014.2671  0.312
2015 Vink M, Kleerekooper I, van den Wildenberg WP, Kahn RS. Impact of aging on frontostriatal reward processing. Human Brain Mapping. 36: 2305-17. PMID 25704624 DOI: 10.1002/Hbm.22771  0.642
2015 Vinkers CH, Joëls M, Milaneschi Y, Gerritsen L, Kahn RS, Penninx BW, Boks MP. Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment. Psychoneuroendocrinology. 54: 90-102. PMID 25686805 DOI: 10.1016/J.Psyneuen.2015.01.018  0.556
2015 Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, Aribisala BS, Armstrong NJ, Bernard M, Bohlken MM, Boks MP, ... ... Kahn RS, et al. Common genetic variants influence human subcortical brain structures. Nature. 520: 224-9. PMID 25607358 DOI: 10.1038/Nature14101  0.684
2015 Maat A, van Montfort SJ, de Nijs J, Derks EM, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Emotion processing in schizophrenia is state and trait dependent. Schizophrenia Research. 161: 392-8. PMID 25543332 DOI: 10.1016/J.Schres.2014.11.027  0.36
2015 Mandl RC, Pasternak O, Cahn W, Kubicki M, Kahn RS, Shenton ME, Hulshoff Pol HE. Comparing free water imaging and magnetization transfer measurements in schizophrenia. Schizophrenia Research. 161: 126-32. PMID 25454797 DOI: 10.1016/J.Schres.2014.09.046  0.34
2015 Houtepen LC, Boks MP, Kahn RS, Joëls M, Vinkers CH. Antipsychotic use is associated with a blunted cortisol stress response: a study in euthymic bipolar disorder patients and their unaffected siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 77-84. PMID 25453485 DOI: 10.1016/J.Euroneuro.2014.10.005  0.594
2015 de Leeuw M, Kahn RS, Vink M. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 41: 94-103. PMID 25368371 DOI: 10.1093/Schbul/Sbu153  0.718
2015 Bootsman F, Brouwer RM, Schnack HG, van Baal GC, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Genetic and environmental influences on cortical surface area and cortical thickness in bipolar disorder. Psychological Medicine. 45: 193-204. PMID 25065711 DOI: 10.1017/S0033291714001251  0.303
2015 van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Neural correlates of trauma-unrelated emotional processing in war veterans with PTSD. Psychological Medicine. 45: 575-87. PMID 25036523 DOI: 10.1017/S0033291714001706  0.598
2015 Hillegers M, De Jong A, Vink M, Pouwels R, Vleeschouwer M, Van Haren N, Kahn R. S.22.01 Clinical and neuro-imaging characteristics of child and adolescent bipolar and schizophrenia offspring European Neuropsychopharmacology. 25: S142. DOI: 10.1016/S0924-977X(15)30101-2  0.658
2015 Pijnenborg G, Timmerman M, Derks E, Fleischhacker W, Kahn R, Aleman A. Do Antipsychotics Affect Insight in Psychosis Differentially? Data From the EUFEST Trial. European Psychiatry. 30: 239. DOI: 10.1016/S0924-9338(15)30194-2  0.388
2014 Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Dermatoglyphics in relation to brain volumes in twins concordant and discordant for bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1885-95. PMID 25451699 DOI: 10.1016/J.Euroneuro.2014.09.010  0.33
2014 Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 25450228 DOI: 10.1038/Mp.2014.152  0.547
2014 Marsman A, Mandl RC, Klomp DW, Bohlken MM, Boer VO, Andreychenko A, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study. Neuroimage. Clinical. 6: 398-407. PMID 25379453 DOI: 10.1016/J.Nicl.2014.10.005  0.348
2014 Stringer S, Kahn RS, de Witte LD, Ophoff RA, Derks EM. Genetic liability for schizophrenia predicts risk of immune disorders. Schizophrenia Research. 159: 347-52. PMID 25266548 DOI: 10.1016/J.Schres.2014.09.004  0.353
2014 van Lutterveld R, van den Heuvel MP, Diederen KM, de Weijer AD, Begemann MJ, Brouwer RM, Daalman K, Blom JD, Kahn RS, Sommer IE. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain : a Journal of Neurology. 137: 2664-9. PMID 24951640 DOI: 10.1093/Brain/Awu167  0.327
2014 van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Impaired right inferior frontal gyrus response to contextual cues in male veterans with PTSD during response inhibition. Journal of Psychiatry & Neuroscience : Jpn. 39: 330-8. PMID 24886789 DOI: 10.1503/Jpn.130223  0.636
2014 Marques TR, Levine SZ, Reichenberg A, Kahn R, Derks EM, Fleischhacker WW, Rabinowitz J, Kapur S. How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1279-88. PMID 24862257 DOI: 10.1016/J.Euroneuro.2014.04.001  0.367
2014 Brouwer RM, Hedman AM, van Haren NE, Schnack HG, Brans RG, Smit DJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of brain volume change and its relation to intelligence. Neuroimage. 100: 676-83. PMID 24816534 DOI: 10.1016/J.Neuroimage.2014.04.072  0.308
2014 Vinkers CH, Joëls M, Milaneschi Y, Kahn RS, Penninx BW, Boks MP. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depression and Anxiety. 31: 737-45. PMID 24753162 DOI: 10.1002/Da.22262  0.547
2014 de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154: 23-9. PMID 24582037 DOI: 10.1016/J.Schres.2014.02.005  0.333
2014 Vink M, Zandbelt BB, Gladwin T, Hillegers M, Hoogendam JM, van den Wildenberg WP, Du Plessis S, Kahn RS. Frontostriatal activity and connectivity increase during proactive inhibition across adolescence and early adulthood. Human Brain Mapping. 35: 4415-27. PMID 24532023 DOI: 10.1002/Hbm.22483  0.801
2014 Vink M, Derks JM, Hoogendam JM, Hillegers M, Kahn RS. Functional differences in emotion processing during adolescence and early adulthood. Neuroimage. 91: 70-6. PMID 24468408 DOI: 10.1016/J.Neuroimage.2014.01.035  0.648
2014 Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 575-84. PMID 24418213 DOI: 10.1016/J.Euroneuro.2013.12.009  0.302
2014 Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, ... ... Kahn RS, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging and Behavior. 8: 153-82. PMID 24399358 DOI: 10.1007/S11682-013-9269-5  0.769
2014 Collin G, Kahn RS, de Reus MA, Cahn W, van den Heuvel MP. Impaired rich club connectivity in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 40: 438-48. PMID 24298172 DOI: 10.1093/Schbul/Sbt162  0.429
2014 Bohlken MM, Brouwer RM, Mandl RC, van Haren NE, Brans RG, van Baal GC, de Geus EJ, Boomsma DI, Kahn RS, Hulshoff Pol HE. Genes contributing to subcortical volumes and intellectual ability implicate the thalamus. Human Brain Mapping. 35: 2632-42. PMID 24038793 DOI: 10.1002/Hbm.22356  0.321
2014 Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, ... ... Kahn RS, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97. PMID 23871474 DOI: 10.1016/J.Biopsych.2013.03.033  0.372
2014 Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, DeYoung J, de Jong S, Sul JH, Eskin E, van Eijk K, van Setten J, Buizer-Voskamp JE, Cantor RM, Lu A, ... ... Kahn RS, et al. Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Molecular Psychiatry. 19: 228-34. PMID 23319000 DOI: 10.1038/Mp.2012.183  0.309
2014 De Leeuw M, Bohlken M, Mandl R, Kahn R, Vink M. P.3.b.022 Fronto–striatal pathways among schizophrenia patients and their unaffected siblings European Neuropsychopharmacology. 24: S504. DOI: 10.1016/S0924-977X(14)70806-5  0.672
2014 Bossong M, Schubart C, Van Hell H, Iseger T, Van Saane W, Jager G, Van Osch P, Jansma J, Kahn R, Boks M, Ramsey N. P.1.i.012 Genetic modulation of acute effects of delta-9-tetrahydrocannabinol (THC) on resting state brain function European Neuropsychopharmacology. 24: S303-S304. DOI: 10.1016/S0924-977X(14)70481-X  0.498
2014 van Rooij S, Rademaker A, Kennis M, Vink M, Kahn R, Geuze E. P.4.001 Neural correlates of non-trauma related emotional processing in war veterans with posttraumatic stress disorder European Neuropsychopharmacology. 24: S81. DOI: 10.1016/S0924-977X(14)70091-4  0.617
2014 Emsley R, Asmal L, Ciliza B, Plessis Sd, Carr J, Kidd M, Vink M, Kahn R. Poster #T68 BRAIN SYSTEMS REGULATING FOOD-INTAKE AND BODY MASS CHANGES DURING ACUTE ANTIPSYCHOTIC TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70885-0  0.656
2014 Vink M, Pouwels R, Hillegers M, Kahn R. Poster #M72 DIFFERENTIAL DEVELOPMENT OF THE REWARD NETWORK IN ADOLESCENT OFFSPRING OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 153: S215-S216. DOI: 10.1016/S0920-9964(14)70622-X  0.662
2014 Pouwels R, Kahn R, Hillegers M, Vink M. Poster #S106 IMPAIRED DEVELOPMENT OF BRAIN ACTIVATION UNDERLYING AFFECTIVE PROCESSING IN ADOLESCENTS AT FAMILIAL RISK FOR BIPOLAR DISORDER OR SCHIZOPHRENIA Schizophrenia Research. 153: S127. DOI: 10.1016/S0920-9964(14)70385-8  0.68
2014 Williams JB, Kane JM, Kahn RS. SCHIZOPHRENIA RESEARCH: THE CHALLENGE OF MEASUREMENT VARIABILITY Schizophrenia Research. 153: S86. DOI: 10.1016/S0920-9964(14)70275-0  0.345
2014 de Leeuw M, Kahn R, Vink M. 5:30 PM REWARD PROCESSING IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 153: S64. DOI: 10.1016/S0920-9964(14)70206-3  0.689
2014 Marsman A, Mandl R, Klomp D, Bohlken M, Boer V, Andreychenko A, Cahn W, Kahn R, Luijten P, Pol HH. 5:15 Pm Gaba And Glutamate In Schizophrenia: A 7T 1H-Mrs Study Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70179-3  0.309
2014 Heuvel Mvd, Collin G, Hillegers M, Reus Md, Kahn W, Kahn R. 5:00 Pm Emerging Evidence Of Affected Anatomical Rich Club Hub Structure In Schizophrenia Patients, Their Healthy Siblings And Their Non-Affected Young Offspring Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70178-1  0.404
2014 Kahn RS, Vink M, Hillegers M, Vleeschouwer M. ABNORMALITIES IN REWARD PROCESSING IN OFFSPRING OF SCHIZOPHRENIA PATIENTS: FRONTAL-STRIATAL ABNORMALITIES AS A HIGH-RISK PHENOTYPE Schizophrenia Research. 153: S38. DOI: 10.1016/S0920-9964(14)70125-2  0.684
2014 Siever LJ, Kahn RS. NEW VISTAS IN DOPAMINE RECEPTOR RESEARCH: IMPLICATIONS FOR NOVEL THERAPIES IN SCHIZOPHRENIA Schizophrenia Research. 153: S5. DOI: 10.1016/S0920-9964(14)70016-7  0.327
2014 Kahn R. Social neuroscience in psychiatry: Of obvious relevance World Psychiatry. 13: 147-148. DOI: 10.1002/Wps.20124  0.38
2013 Jansma JM, van Raalten TR, Boessen R, Neggers SF, Jacobs RH, Kahn RS, Ramsey NF. fMRI guided rTMS evidence for reduced left prefrontal involvement after task practice. Plos One. 8: e80256. PMID 24376494 DOI: 10.1371/Journal.Pone.0080256  0.529
2013 Hoogendam JM, Kahn RS, Hillegers MH, van Buuren M, Vink M. Different developmental trajectories for anticipation and receipt of reward during adolescence. Developmental Cognitive Neuroscience. 6: 113-24. PMID 24055865 DOI: 10.1016/J.Dcn.2013.08.004  0.635
2013 de Leeuw M, Kahn RS, Zandbelt BB, Widschwendter CG, Vink M. Working memory and default mode network abnormalities in unaffected siblings of schizophrenia patients. Schizophrenia Research. 150: 555-62. PMID 24051015 DOI: 10.1016/J.Schres.2013.08.016  0.813
2013 Bossong MG, Jansma JM, van Hell HH, Jager G, Kahn RS, Ramsey NF. Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function. Plos One. 8: e70074. PMID 23936144 DOI: 10.1371/Journal.Pone.0070074  0.561
2013 Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, ... ... Kahn RS, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics. 45: 984-94. PMID 23933821 DOI: 10.1038/Ng.2711  0.308
2013 Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1687-97. PMID 23928295 DOI: 10.1016/J.Euroneuro.2013.06.009  0.515
2013 Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. Jama Psychiatry. 70: 1107-12. PMID 23925787 DOI: 10.1001/Jamapsychiatry.2013.155  0.349
2013 Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS. NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies. Neuroscience and Biobehavioral Reviews. 37: 1587-96. PMID 23792047 DOI: 10.1016/J.Neubiorev.2013.06.007  0.321
2013 van den Heuvel MP, Sporns O, Collin G, Scheewe T, Mandl RC, Cahn W, Goñi J, Hulshoff Pol HE, Kahn RS. Abnormal rich club organization and functional brain dynamics in schizophrenia. Jama Psychiatry. 70: 783-92. PMID 23739835 DOI: 10.1001/Jamapsychiatry.2013.1328  0.391
2013 Jansma JM, van Hell HH, Vanderschuren LJ, Bossong MG, Jager G, Kahn RS, Ramsey NF. THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. Translational Psychiatry. 3: e234. PMID 23443360 DOI: 10.1038/Tp.2013.6  0.5
2013 Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 33: 258-61. PMID 23422388 DOI: 10.1097/Jcp.0B013E3182856886  0.366
2013 van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn W, Ripke S, Ophoff RA, Kahn RS. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine. 43: 2563-70. PMID 23410598 DOI: 10.1017/S0033291713000196  0.399
2013 Terwisscha van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ. Fibroblast growth factors in neurodevelopment and psychopathology. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 19: 479-94. PMID 23343917 DOI: 10.1177/1073858412472399  0.312
2013 Diederen KM, Neggers SF, de Weijer AD, van Lutterveld R, Daalman K, Eickhoff SB, Clos M, Kahn RS, Sommer IE. Aberrant resting-state connectivity in non-psychotic individuals with auditory hallucinations. Psychological Medicine. 43: 1685-96. PMID 23199762 DOI: 10.1017/S0033291712002541  0.351
2013 Vorstman JA, Anney RJ, Derks EM, Gallagher L, Gill M, de Jonge MV, van Engeland H, Kahn RS, Ophoff RA. No evidence that common genetic risk variation is shared between schizophrenia and autism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 55-60. PMID 23193033 DOI: 10.1002/Ajmg.B.32121  0.376
2013 Renes RA, Vermeulen L, Kahn RS, Aarts H, van Haren NE. Abnormalities in the establishment of feeling of self-agency in schizophrenia. Schizophrenia Research. 143: 50-4. PMID 23178108 DOI: 10.1016/J.Schres.2012.10.024  0.343
2013 Zandbelt BB, Bloemendaal M, Hoogendam JM, Kahn RS, Vink M. Transcranial magnetic stimulation and functional MRI reveal cortical and subcortical interactions during stop-signal response inhibition. Journal of Cognitive Neuroscience. 25: 157-74. PMID 23066733 DOI: 10.1162/Jocn_A_00309  0.781
2013 Collin G, de Reus MA, Cahn W, Hulshoff Pol HE, Kahn RS, van den Heuvel MP. Disturbed grey matter coupling in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 46-54. PMID 23036782 DOI: 10.1016/J.Euroneuro.2012.09.001  0.394
2013 van den Heuvel MP, van Soelen IL, Stam CJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Genetic control of functional brain network efficiency in children. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 19-23. PMID 22819192 DOI: 10.1016/J.Euroneuro.2012.06.007  0.313
2013 van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology. 38: 155-65. PMID 22776420 DOI: 10.1016/J.Psyneuen.2012.05.015  0.533
2013 Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/J.Euroneuro.2012.04.019  0.353
2013 Zandbelt BB, Bloemendaal M, Neggers SF, Kahn RS, Vink M. Expectations and violations: delineating the neural network of proactive inhibitory control. Human Brain Mapping. 34: 2015-24. PMID 22359406 DOI: 10.1002/Hbm.22047  0.777
2013 Howes OD, Shotbolt P, Bloomfield M, Daalman K, Demjaha A, Diederen KM, Ibrahim K, Kim E, McGuire P, Kahn RS, Sommer IE. Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophrenia Bulletin. 39: 807-14. PMID 22282457 DOI: 10.1093/Schbul/Sbr195  0.31
2013 Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophrenia Bulletin. 39: 120-9. PMID 21746807 DOI: 10.1093/Schbul/Sbr069  0.388
2013 Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Poster sessionsP.1.g. Basic and clinical neuroscience – NeuropharmacologyP.1.g.024 Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70311-0  0.3
2013 De Leeuw M, Kahn R, Vink M. S.07.07 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S122. DOI: 10.1016/S0924-977X(13)70151-2  0.674
2013 de Leeuw M, Vink M, Kahn R. P.4.006 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S72-S73. DOI: 10.1016/S0924-977X(13)70081-6  0.613
2012 van Buuren M, Vink M, Kahn RS. Default-mode network dysfunction and self-referential processing in healthy siblings of schizophrenia patients. Schizophrenia Research. 142: 237-43. PMID 23099059 DOI: 10.1016/J.Schres.2012.09.017  0.702
2012 van der Kemp WJ, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophrenia Research. 141: 153-61. PMID 22981812 DOI: 10.1016/J.Schres.2012.08.014  0.363
2012 He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D. Schizophrenia shows a unique metabolomics signature in plasma Translational Psychiatry. 2. PMID 22892715 DOI: 10.1038/Tp.2012.76  0.39
2012 van Soelen IL, Brouwer RM, Peper JS, van Leeuwen M, Koenis MM, van Beijsterveldt TC, Swagerman SC, Kahn RS, Hulshoff Pol HE, Boomsma DI. Brain SCALE: brain structure and cognition: an adolescent longitudinal twin study into the genetic etiology of individual differences. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 15: 453-67. PMID 22856378 DOI: 10.1017/Thg.2012.4  0.309
2012 Geyer MA, Olivier B, Joëls M, Kahn RS. From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends in Pharmacological Sciences. 33: 515-21. PMID 22810174 DOI: 10.1016/J.Tips.2012.06.006  0.348
2012 de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, Ori AP, Vi N, Mulder F, Blom JD, Glenthøj B, Schubart CD, Cahn W, Kahn RS, Horvath S, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. Plos One. 7: e39498. PMID 22761806 DOI: 10.1371/Journal.Pone.0039498  0.375
2012 Collin G, Derks EM, van Haren NE, Schnack HG, Hulshoff Pol HE, Kahn RS, Cahn W. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophrenia Research. 138: 171-6. PMID 22534419 DOI: 10.1016/J.Schres.2012.03.036  0.393
2012 Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, ... ... Kahn RS, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics. 44: 552-61. PMID 22504417 DOI: 10.1038/Ng.2250  0.766
2012 Hulshoff Pol HE, van Baal GC, Schnack HG, Brans RG, van der Schot AC, Brouwer RM, van Haren NE, Lepage C, Collins DL, Evans AC, Boomsma DI, Nolen W, Kahn RS. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Archives of General Psychiatry. 69: 349-59. PMID 22474104 DOI: 10.1001/Archgenpsychiatry.2011.1615  0.418
2012 de Jong S, van Eijk KR, Zeegers DW, Strengman E, Janson E, Veldink JH, van den Berg LH, Cahn W, Kahn RS, Boks MP, Ophoff RA. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. European Journal of Human Genetics : Ejhg. 20: 1004-8. PMID 22433715 DOI: 10.1038/Ejhg.2012.38  0.376
2012 van Haren NE, Rijsdijk F, Schnack HG, Picchioni MM, Toulopoulou T, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Huttunen MO, Boomsma DI, Hulshoff Pol HE, Murray RM, Kahn RS. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biological Psychiatry. 71: 915-21. PMID 22341827 DOI: 10.1016/J.Biopsych.2012.01.010  0.717
2012 Bossong MG, Jansma JM, van Hell HH, Jager G, Oudman E, Saliasi E, Kahn RS, Ramsey NF. Effects of δ9-tetrahydrocannabinol on human working memory function. Biological Psychiatry. 71: 693-9. PMID 22341370 DOI: 10.1016/J.Biopsych.2012.01.008  0.59
2012 Luykx JJ, Bakker SC, Lentjes E, Boks MP, van Geloven N, Eijkemans MJ, Janson E, Strengman E, de Lepper AM, Westenberg H, Klopper KE, Hoorn HJ, Gelissen HP, Jordan J, Tolenaar NM, ... ... Kahn RS, et al. Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid. Plos One. 7: e30497. PMID 22312427 DOI: 10.1371/Journal.Pone.0030497  0.545
2012 Bossong MG, Jager G, van Hell HH, Zuurman L, Jansma JM, Mehta MA, van Gerven JM, Kahn RS, Ramsey NF. Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. Journal of Cognitive Neuroscience. 24: 588-99. PMID 22066583 DOI: 10.1162/Jocn_A_00156  0.527
2012 van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, van Gerven J, Kahn RS, Ramsey NF. Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology. 219: 981-90. PMID 21822593 DOI: 10.1007/S00213-011-2428-8  0.529
2012 Machielsen M, Beduin AS, Dekker N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology (Oxford, England). 26: 189-95. PMID 21768161 DOI: 10.1177/0269881111408957  0.324
2012 van Rijn S, Swaab H, Baas D, de Haan E, Kahn RS, Aleman A. Neural systems for social cognition in Klinefelter syndrome (47,XXY): evidence from fMRI. Social Cognitive and Affective Neuroscience. 7: 689-97. PMID 21737434 DOI: 10.1093/Scan/Nsr041  0.321
2012 Klomp A, Koolschijn PC, Hulshoff Pol HE, Kahn RS, Haren NE. Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 281-8. PMID 21733239 DOI: 10.1017/S1461145711000794  0.38
2012 van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. The course of brain abnormalities in schizophrenia: can we slow the progression? Journal of Psychopharmacology (Oxford, England). 26: 8-14. PMID 21730018 DOI: 10.1177/0269881111408964  0.39
2012 Diederen KM, Daalman K, de Weijer AD, Neggers SF, van Gastel W, Blom JD, Kahn RS, Sommer IE. Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophrenia Bulletin. 38: 1074-82. PMID 21527413 DOI: 10.1093/Schbul/Sbr033  0.376
2012 van Venrooij JA, Fluitman SB, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HG, Kahn RS, Gispen-de Wied CC. Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. 38: 272-9. PMID 20558533 DOI: 10.1093/Schbul/Sbq062  0.585
2012 Leeuw Md, Vink M, Kahn RS. Reward processing in unaffected siblings of schizophrenia patients: an fMRI study F1000research. 3. DOI: 10.7490/F1000Research.1092030.1  0.685
2012 Vorstman l, Anney R, Derks E, Gallagher L, Gill M, Jonge Md, Engeland Hv, Kahn R, Ophoff R. Poster #112 NO EVIDENCE THAT COMMON GENETIC RISK VARIANTS ARE SHARED BETWEEN SCHIZOPHRENIA AND AUTISM Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70945-3  0.36
2012 Vink M, Zandbelt BB, van Buuren M, Kahn RS. Poster #36 REDUCED PROACTIVE INHIBITORY CONTROL IN SCHIZOPHRENIA PATIENTS AND THEIR UNAFFECTED SIBLINGS Schizophrenia Research. 136: S293-S294. DOI: 10.1016/S0920-9964(12)70869-1  0.805
2012 Collin G, Van den Heuvel MP, De Reus MA, Boos HB, Calm W, Pol HEH, Kahn RS. Poster #48 FRONTOSTRIATAL DEPENDENCY IN GREY MATTER VOLUME IS REDUCED IN SCHIZOPHRENIA Schizophrenia Research. 136: S202-S203. DOI: 10.1016/S0920-9964(12)70620-5  0.379
2012 de Leeuw M, Vink M, Zandbelt BB, Kahn RS. Poster #22 HYPERACTIVATION IN WORKING MEMORY CIRCUITS IN SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 136: S99. DOI: 10.1016/S0920-9964(12)70338-9  0.797
2012 Collin G, Pol HEH, Haijma SV, Cahn W, Kahn RS, Heuvel MPVd. Poster #19 IMPAIRED CEREBELLAR FUNCTIONAL CONNECTIVITY IN SCHIZOPHRENIA PATIENTS AND THEIR HEALTHY SIBLINGS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70335-3  0.422
2011 Collin G, Hulshoff Pol HE, Haijma SV, Cahn W, Kahn RS, van den Heuvel MP. Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. Frontiers in Psychiatry. 2: 73. PMID 22203807 DOI: 10.3389/Fpsyt.2011.00073  0.43
2011 Kas MJ, Kahn RS, Collier DA, Waddington JL, Ekelund J, Porteous DJ, Schughart K, Hovatta I. Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man. Science Translational Medicine. 3: 102mr3. PMID 21957171 DOI: 10.1126/Scitranslmed.3002917  0.343
2011 Zandbelt BB, van Buuren M, Kahn RS, Vink M. Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biological Psychiatry. 70: 1151-8. PMID 21903198 DOI: 10.1016/J.Biopsych.2011.07.028  0.815
2011 van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry. 68: 871-80. PMID 21893656 DOI: 10.1001/Archgenpsychiatry.2011.88  0.372
2011 Daalman K, van Zandvoort M, Bootsman F, Boks M, Kahn R, Sommer I. Auditory verbal hallucinations and cognitive functioning in healthy individuals. Schizophrenia Research. 132: 203-7. PMID 21839618 DOI: 10.1016/J.Schres.2011.07.013  0.341
2011 Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 72: 955-61. PMID 21824456 DOI: 10.4088/Jcp.10M06529  0.377
2011 van Hell HH, Bossong MG, Jager G, Kahn RS, Ramsey NF. Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition. International Journal of Methods in Psychiatric Research. 20: 10-27. PMID 21574207 DOI: 10.1002/Mpr.327  0.539
2011 van Buuren M, Vink M, Rapcencu AE, Kahn RS. Exaggerated brain activation during emotion processing in unaffected siblings of patients with schizophrenia. Biological Psychiatry. 70: 81-7. PMID 21531384 DOI: 10.1016/J.Biopsych.2011.03.011  0.702
2011 van Veelen NM, Vink M, Ramsey NF, van Buuren M, Hoogendam JM, Kahn RS. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. Schizophrenia Research. 129: 156-62. PMID 21497488 DOI: 10.1016/J.Schres.2011.03.026  0.752
2011 Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, Termorshuizen F, Kahn RS, Boks MP, Ophoff RA. Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophrenia Research. 129: 128-32. PMID 21489755 DOI: 10.1016/J.Schres.2011.03.021  0.633
2011 van Hell HH, Bossong MG, Jager G, Kristo G, van Osch MJ, Zelaya F, Kahn RS, Ramsey NF. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1377-88. PMID 21489346 DOI: 10.1017/S1461145711000526  0.552
2011 Daalman K, Boks MP, Diederen KM, de Weijer AD, Blom JD, Kahn RS, Sommer IE. The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. The Journal of Clinical Psychiatry. 72: 320-5. PMID 21450152 DOI: 10.4088/Jcp.09M05797Yel  0.333
2011 van Veelen NM, Vink M, Ramsey NF, Sommer IE, van Buuren M, Hoogendam JM, Kahn RS. Reduced language lateralization in first-episode medication-naive schizophrenia. Schizophrenia Research. 127: 195-201. PMID 21237617 DOI: 10.1016/J.Schres.2010.12.013  0.735
2011 Kahn RS, Linszen DH, Van Os J, Wiersma D, Bruggeman R, Cahn W, De Haan L, Krabbendam L, Myin-Germeys I. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: An analysis of patient-sibling and sibling-control pairs Archives of General Psychiatry. 68: 138-147. PMID 20921112 DOI: 10.1001/Archgenpsychiatry.2010.132  0.307
2011 Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, de Jonge M, Hennekam EA, Janson E, Staal WG, van der Zwaag B, Burbach JP, Kahn RS, Emanuel BS, van Engeland H, Ophoff RA. A double hit implicates DIAPH3 as an autism risk gene. Molecular Psychiatry. 16: 442-51. PMID 20308993 DOI: 10.1038/Mp.2010.26  0.636
2011 van Hell H, Jansma J, Bossong M, Kahn R, Ramsey N. P.6.c.005 Endocannabinoid involvement in brain reward processing in nicotine addiction European Neuropsychopharmacology. 21: S578. DOI: 10.1016/S0924-977X(11)70945-2  0.483
2011 van Hell H, Jansma J, Bossong M, Jager G, Noorman K, Kahn R, Ramsey N. P.1.e.031 Endocannabinoids may not be involved in response inhibition in humans European Neuropsychopharmacology. 21: S321. DOI: 10.1016/S0924-977X(11)70509-0  0.468
2011 Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.007 The effects of delta9-tetrahydrocannabinol (THC) on human brain function involved in emotional processing: a pharmacological fMRI study European Neuropsychopharmacology. 21: S307. DOI: 10.1016/S0924-977X(11)70485-0  0.499
2011 Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.006 Involvement of the endocannabinoid system in executive function: a pharmacological fMRI study with delta9-tetrahydrocannabinol (THC) European Neuropsychopharmacology. 21: S306-S307. DOI: 10.1016/S0924-977X(11)70484-9  0.485
2011 Van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: An fMRI study | Efectos crónicos del consumo de cannabis sobre el sistema de recompensa humano: un estudio de RMf Psiquiatria Biologica. 18: 45-54. DOI: 10.1016/J.Psiq.2011.08.003  0.676
2010 Diederen KM, De Weijer AD, Daalman K, Blom JD, Neggers SF, Kahn RS, Sommer IE. Decreased language lateralization is characteristic of psychosis, not auditory hallucinations. Brain : a Journal of Neurology. 133: 3734-44. PMID 21097491 DOI: 10.1093/Brain/Awq313  0.324
2010 Schnack HG, van Haren NE, Brouwer RM, van Baal GC, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Hulshoff Pol HE. Mapping reliability in multicenter MRI: voxel-based morphometry and cortical thickness. Human Brain Mapping. 31: 1967-82. PMID 21086550 DOI: 10.1002/Hbm.20991  0.459
2010 Van der Schot A, Kahn R, Ramsey N, Nolen W, Vink M. Trait and state dependent functional impairments in bipolar disorder. Psychiatry Research. 184: 135-42. PMID 21050725 DOI: 10.1016/J.Pscychresns.2010.07.009  0.729
2010 Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 855-65. PMID 20863671 DOI: 10.1016/J.Euroneuro.2010.08.008  0.383
2010 van der Schot AC, Vonk R, Brouwer RM, van Baal GC, Brans RG, van Haren NE, Schnack HG, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Genetic and environmental influences on focal brain density in bipolar disorder. Brain : a Journal of Neurology. 133: 3080-92. PMID 20837502 DOI: 10.1093/Brain/Awq236  0.345
2010 Vinkers CH, Mirza NR, Olivier B, Kahn RS. The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline. Expert Opinion On Investigational Drugs. 19: 1217-33. PMID 20812877 DOI: 10.1517/13543784.2010.513382  0.352
2010 van Veelen NM, Vink M, Ramsey NF, Kahn RS. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia. Schizophrenia Research. 123: 22-9. PMID 20724113 DOI: 10.1016/J.Schres.2010.07.004  0.765
2010 de Weijer AD, Mandl RC, Sommer IE, Vink M, Kahn RS, Neggers SF. Human fronto-tectal and fronto-striatal-tectal pathways activate differently during anti-saccades. Frontiers in Human Neuroscience. 4: 41. PMID 20631846 DOI: 10.3389/Fnhum.2010.00041  0.639
2010 Brans RG, Kahn RS, Schnack HG, van Baal GC, Posthuma D, van Haren NE, Lepage C, Lerch JP, Collins DL, Evans AC, Boomsma DI, Hulshoff Pol HE. Brain plasticity and intellectual ability are influenced by shared genes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 5519-24. PMID 20410105 DOI: 10.1523/Jneurosci.5841-09.2010  0.32
2010 Diederen KM, Neggers SF, Daalman K, Blom JD, Goekoop R, Kahn RS, Sommer IE. Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. The American Journal of Psychiatry. 167: 427-35. PMID 20123912 DOI: 10.1176/Appi.Ajp.2009.09040456  0.35
2010 van Buuren M, Gladwin TE, Zandbelt BB, Kahn RS, Vink M. Reduced functional coupling in the default-mode network during self-referential processing. Human Brain Mapping. 31: 1117-27. PMID 20108218 DOI: 10.1002/Hbm.20920  0.775
2010 van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: an fMRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 153-63. PMID 20061126 DOI: 10.1016/J.Euroneuro.2009.11.010  0.699
2010 Réthelyi JM, Bakker SC, Polgár P, Czobor P, Strengman E, Pásztor PI, Kahn RS, Bitter I. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 792-801. PMID 19937977 DOI: 10.1002/Ajmg.B.31049  0.369
2010 Koning JP, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophrenia Bulletin. 36: 723-31. PMID 18990712 DOI: 10.1093/Schbul/Sbn146  0.39
2010 Vink M, Zandbelt BB, Buuren Mv, Kahn RS. Stop-signal response inhibition deficits in schizophrenia patients and their unaffected siblings F1000research. 1. DOI: 10.7490/F1000Research.694.1  0.804
2010 Jager G, van Hell H, Bossong M, Kristo G, Kahn R, Ramsey N. P.1.e.009 Delta9-THC induces non-specific psychotropic effects reflected in resting-state brain function: a pharmaco-imaging study European Neuropsychopharmacology. 20: S293. DOI: 10.1016/S0924-977X(10)70388-6  0.502
2010 Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.1.e.005 Delta9-tetrahydrocannabinol (THC) impairs working memory system capacity: a pharmacological MRI study European Neuropsychopharmacology. 20: S290-S291. DOI: 10.1016/S0924-977X(10)70384-9  0.481
2010 van Hell H, Jager G, Brouwer A, Bossong M, Kahn R, Ramsey N. P.3.024 Addiction proneness: contribution of the endocannabinoid system and reward processing European Neuropsychopharmacology. 20: S82. DOI: 10.1016/S0924-977X(10)70096-1  0.472
2010 Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.3.003 Involvement of the endocannabinoid system in working memory: a pharmacological MRI study with delta9-THC European Neuropsychopharmacology. 20: S64. DOI: 10.1016/S0924-977X(10)70075-4  0.479
2010 Widschwendter CG, Vink M, Zandbelt BB, Kahn RS. EVIDENCE FOR DECREASED FRONTO-STRIATAL FUNCTIONING IN SCHIZOPHRENIA DURING WORKING MEMORY Schizophrenia Research. 117: 476. DOI: 10.1016/J.Schres.2010.02.897  0.795
2010 Hoogendam JM, van Veelen NM, Vink M, Kahn RS. DECREASED LANGUAGE LATERALIZATION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 475-476. DOI: 10.1016/J.Schres.2010.02.896  0.659
2010 van Buuren M, Vink M, Kahn RS. ABERRANT COUPLING WITHIN THE DEFAULT-MODE NETWORK DURING SELF-REFERENTIAL PROCESSING IN HEALTHY SIBLINGS OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 117: 474. DOI: 10.1016/J.Schres.2010.02.893  0.665
2010 Schnack HG, Haren NEMv, Brouwer RM, Baal GCMv, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Pol HEH. Mapping Reliability Of Multicenter Mri: Cortical Thickness And Voxel-Based Morphometry Schizophrenia Research. 117: 461-461. DOI: 10.1016/J.Schres.2010.02.861  0.543
2010 Terwisscha van Schel AF, Bakker SC, van Haren NE, Pol HEH, Cahn W, Buizer-Voskamp JE, Gladwin TE, Vorstman JA, Ophoff RA, Kahn RS. ASSOCIATION STUDY OF CNVS WITH BRAIN VOLUME AND BRAIN VOLUME CHANGE OVER 5 YEARS IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS Schizophrenia Research. 117: 454. DOI: 10.1016/J.Schres.2010.02.845  0.385
2010 van Veelen NM, Vink M, Ramsey NF, Kahn RS. LEFT PRE-FRONTAL LOBE DYSFUNCTION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 359. DOI: 10.1016/J.Schres.2010.02.631  0.733
2010 Buizer-Voskamp JE, Laan W, Boks MPM, Staal WG, Hennekam EAM, Aukes MF, Kahn RS, Ophoff RA. Parental Age And The Risk Of Psychiatric Disorders Schizophrenia Research. 117: 194-194. DOI: 10.1016/J.Schres.2010.02.255  0.6
2010 van Haren NE, Rijsdijk F, Schnack H, Picchioni M, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Boomsma D, Hulshoff Pol HE, Murray RM, Kahn RS. THE STAR CONSORTIUM: DO GENES OR ENVIRONMENT EXPLAIN THE ASSOCIATION BETWEEN SCHIZOPHRENIA AND A SMALLER BRAIN? Schizophrenia Research. 117: 171-172. DOI: 10.1016/J.Schres.2010.02.200  0.364
2009 Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophrenia Research. 115: 104-14. PMID 19822407 DOI: 10.1016/J.Schres.2009.09.022  0.342
2009 Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophrenia Research. 115: 97-103. PMID 19819114 DOI: 10.1016/J.Schres.2009.09.019  0.315
2009 Kemner C, Foxe JJ, Tankink JE, Kahn RS, Lamme VA. Abnormal timing of visual feedback processing in young adults with schizophrenia. Neuropsychologia. 47: 3105-10. PMID 19631672 DOI: 10.1016/J.Neuropsychologia.2009.07.009  0.35
2009 Grootens KP, van Veelen NM, Peuskens J, Sabbe BG, Thys E, Buitelaar JK, Verkes RJ, Kahn RS. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophrenia Bulletin. 37: 352-61. PMID 19542525 DOI: 10.1093/Schbul/Sbp037  0.386
2009 van 't Wout M, van Rijn S, Jellema T, Kahn RS, Aleman A. Deficits in implicit attention to social signals in schizophrenia and high risk groups: behavioural evidence from a new illusion. Plos One. 4: e5581. PMID 19440352 DOI: 10.1371/Journal.Pone.0005581  0.371
2009 Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, ... ... Kahn RS, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). The American Journal of Psychiatry. 166: 675-82. PMID 19369319 DOI: 10.1176/Appi.Ajp.2008.08060806  0.355
2009 Peper JS, Schnack HG, Brouwer RM, Van Baal GC, Pjetri E, Székely E, van Leeuwen M, van den Berg SM, Collins DL, Evans AC, Boomsma DI, Kahn RS, Hulshoff Pol HE. Heritability of regional and global brain structure at the onset of puberty: a magnetic resonance imaging study in 9-year-old twin pairs. Human Brain Mapping. 30: 2184-96. PMID 19294640 DOI: 10.1002/Hbm.20660  0.321
2009 van der Schot AC, Vonk R, Brans RG, van Haren NE, Koolschijn PC, Nuboer V, Schnack HG, van Baal GC, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Archives of General Psychiatry. 66: 142-51. PMID 19188536 DOI: 10.1001/Archgenpsychiatry.2008.541  0.329
2009 van Buuren M, Gladwin TE, Zandbelt BB, van den Heuvel M, Ramsey NF, Kahn RS, Vink M. Cardiorespiratory effects on default-mode network activity as measured with fMRI. Human Brain Mapping. 30: 3031-42. PMID 19180557 DOI: 10.1002/Hbm.20729  0.779
2009 Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 823-32. PMID 19154656 DOI: 10.1017/S1461145708009814  0.585
2009 Grootens KP, Vermeeren L, Verkes RJ, Buitelaar JK, Sabbe BG, van Veelen N, Kahn RS, Hulstijn W. Psychomotor planning is deficient in recent-onset schizophrenia. Schizophrenia Research. 107: 294-302. PMID 19008079 DOI: 10.1016/J.Schres.2008.09.032  0.394
2009 Peper JS, Brouwer RM, Schnack HG, Baal GCMv, Leeuwen Mv, Berg SMvd, Waal HDd, Boomsma DI, Kahn RS, Pol HEH. Sex steroids and brain structure in pubertal boys and girls Psychoneuroendocrinology. 34: 332-342. PMID 18980810 DOI: 10.1016/J.Psyneuen.2008.09.012  0.316
2009 Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, Rappaport EF, Beemer FA, Emanuel BS, Kahn RS, van Engeland H, Kemner C. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 739-46. PMID 18769474 DOI: 10.1038/Npp.2008.132  0.338
2009 Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JM, Ramsey NF, Lammertsma AA, Kahn RS. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 759-66. PMID 18754005 DOI: 10.1016/J.Neuroimage.2008.04.231  0.502
2009 Vorstman JA, Chow EW, Ophoff RA, van Engeland H, Beemer FA, Kahn RS, Sinke RJ, Bassett AS. Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 430-3. PMID 18646052 DOI: 10.1002/Ajmg.B.30827  0.381
2009 Vink M, Zandbelt B, van Buuren M, Kahn R, Gladwin T. Anticipation and execution of response inhibition Neuroimage. 47: S190. DOI: 10.1016/S1053-8119(09)72124-X  0.759
2009 van Buuren M, Gladwin T, Zandbelt B, Kahn R, Vink M. Activity and connectivity within the default-mode network during self-referential processing after removal of cardiorespiratory confounds Neuroimage. 47: S133. DOI: 10.1016/S1053-8119(09)71304-7  0.76
2009 Zandbelt B, Hoogendam J, Van Buuren M, Sack A, Kahn R, Vink M. Repetitive Transcranial Magnetic Stimulation Alters Resting-State Functional Connectivity Neuroimage. 47: S74. DOI: 10.1016/S1053-8119(09)70478-1  0.76
2009 Bossong M, Van Hell H, Jager G, Brouwer A, Kahn R, Ramsey N. P.1.e.015 Involvement of the endocannabinoid system in associative memory: a pharmacological MRI study European Neuropsychopharmacology. 19: S308-S309. DOI: 10.1016/S0924-977X(09)70459-6  0.481
2009 van Hell H, Bossong M, Jager G, Saliasi E, Kahn R, Ramsey N. P.1.e.014 The acute effects of delta-9-tetrahydro-cannabinol (THC) on brain activity during working memory European Neuropsychopharmacology. 19: S308. DOI: 10.1016/S0924-977X(09)70458-4  0.495
2009 Buizer-Voskamp J, Muntjewerff J, Vorstman J, Franke L, Hochstenbach P, Ophoff R, Kahn R. P.1.04 Schizophrenia and cytogenetic aberrations: in search of susceptibility genes and pathways European Neuropsychopharmacology. 19: S5-S6. DOI: 10.1016/S0924-977X(09)70007-0  0.348
2008 Mandl RC, Schnack HG, Zwiers MP, van der Schaaf A, Kahn RS, Hulshoff Pol HE. Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. Plos One. 3: e3631. PMID 18982065 DOI: 10.1371/Journal.Pone.0003631  0.306
2008 Brans RG, van Haren NE, van Baal GC, Staal WG, Schnack HG, Kahn RS, Hulshoff Pol HE. Longitudinal MRI study in schizophrenia patients and their healthy siblings. The British Journal of Psychiatry : the Journal of Mental Science. 193: 422-3. PMID 18978326 DOI: 10.1192/Bjp.Bp.107.041467  0.697
2008 Zandbelt BB, Gladwin TE, Raemaekers M, van Buuren M, Neggers SF, Kahn RS, Ramsey NF, Vink M. Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage. 42: 196-206. PMID 18538585 DOI: 10.1016/J.Neuroimage.2008.04.183  0.77
2008 Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 371: 1085-97. PMID 18374841 DOI: 10.1016/S0140-6736(08)60486-9  0.35
2008 van Rijn S, Aleman A, Swaab H, Vink M, Sommer I, Kahn RS. Effects of an extra X chromosome on language lateralization: an fMRI study with Klinefelter men (47,XXY). Schizophrenia Research. 101: 17-25. PMID 18372164 DOI: 10.1016/J.Schres.2008.02.001  0.642
2008 Rietkerk T, Boks MPM, Sommer IE, Liddle PF, Ophoff RA, Kahn RS. The genetics of symptom dimensions of schizophrenia: Review and meta-analysis Schizophrenia Research. 102: 197-205. PMID 18328672 DOI: 10.1016/J.Schres.2008.01.023  0.353
2008 Baas D, Aleman A, Vink M, Ramsey NF, de Haan EH, Kahn RS. Evidence of altered cortical and amygdala activation during social decision-making in schizophrenia. Neuroimage. 40: 719-27. PMID 18261933 DOI: 10.1016/J.Neuroimage.2007.12.039  0.74
2008 Boks MPM, Hoogendoorn M, Jungerius BJ, Bakker SC, Sommer IE, Sinke RJ, Ophoff RA, Kahn RS. Do mood symptoms subdivide the schizophrenia phenotype? Association of the GMP6A gene with a depression subgroup American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 147: 707-711. PMID 18163405 DOI: 10.1002/Ajmg.B.30667  0.408
2008 van Raalten TR, Ramsey NF, Jansma JM, Jager G, Kahn RS. Automatization and working memory capacity in schizophrenia. Schizophrenia Research. 100: 161-71. PMID 18155446 DOI: 10.1016/J.Schres.2007.10.035  0.571
2008 Sommer IE, Cohen-Kettenis PT, van Raalten T, Vd Veer AJ, Ramsey LE, Gooren LJ, Kahn RS, Ramsey NF. Effects of cross-sex hormones on cerebral activation during language and mental rotation: An fMRI study in transsexuals. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 215-21. PMID 17997284 DOI: 10.1016/J.Euroneuro.2007.10.002  0.492
2008 Baas D, van't Wout M, Aleman A, Kahn RS. Social judgement in clinically stable patients with schizophrenia and healthy relatives: behavioural evidence of social brain dysfunction. Psychological Medicine. 38: 747-54. PMID 17988413 DOI: 10.1017/S0033291707001729  0.394
2008 Hoogendoorn MLC, Vorstman JAS, Jalali GR, Selten JP, Sinke RJ, Emanuel BS, Kahn RS. Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia Schizophrenia Research. 98: 84-88. PMID 17964762 DOI: 10.1016/J.Schres.2007.09.025  0.363
2008 Scholten MR, Aleman A, Kahn RS. The processing of emotional prosody and semantics in schizophrenia: relationship to gender and IQ. Psychological Medicine. 38: 887-98. PMID 17949518 DOI: 10.1017/S0033291707001742  0.307
2008 Jungerius BJ, Bakker SC, Monsuur AJ, Sinke RJ, Kahn RS, Wijmenga C. Is MYO9B the missing link between schizophrenia and celiac disease? American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 351-5. PMID 17948900 DOI: 10.1002/Ajmg.B.30605  0.375
2008 Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, Faas BH, Knoers NV, Cahn W, Kahn RS, Edelmann L, Davis KL, Silverman JM, Brunner HG, van Kessel AG, Wijmenga C, et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Molecular Psychiatry. 13: 261-6. PMID 17646849 DOI: 10.1038/Sj.Mp.4002049  0.323
2008 Jager G, de Win MM, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 247-58. PMID 17460617 DOI: 10.1038/Sj.Npp.1301415  0.643
2008 van Veelen N, Vink M, Ramsey N, Kahn R. P.3.17 Do patients benefit from practice? An fMRI study in first episode schizophrenia European Neuropsychopharmacology. 18: s76-s77. DOI: 10.1016/S0924-977X(08)70088-9  0.741
2008 Koning J, van Harten P, Aleman A, Kahn RS. SPONTANEOUS DYSKINESIA AND PARKINSONISMIN SCHIZOPHRENIA AND THEIR SIBLINGS. A SYSTEMATIC REVIEWAND META-ANALYSIS Schizophrenia Research. 102: 153. DOI: 10.1016/S0920-9964(08)70466-3  0.351
2008 Schnack H, Haren Nv, Picchioni M, Weisbrod M, Sauer H, Cannon T, Huttunen M, Murray R, Kahn R, Pol HH. A Multicenter Mri Schizophrenia Study: Reliability Of Voxel-Based Morphometry Schizophrenia Research. 102: 75. DOI: 10.1016/S0920-9964(08)70231-7  0.537
2008 Bakker S, van Haren N, Hoogendoorn M, Koolschijn C, Pol HH, Sinke R, Ophoff R, Kahn R. ASSOCIATION OF FIBROBLAST GROWTH FACTOR 2 (FGF2) WITH HIPPOCAMPAL VOLUME IN DUTCH SCHIZOPHRENIA PATIENTS Schizophrenia Research. 102: 16. DOI: 10.1016/S0920-9964(08)70053-7  0.408
2007 Van't Wout M, van Dijke A, Aleman A, Kessels RP, Pijpers W, Kahn RS. Fearful faces in schizophrenia: the relationship between patient characteristics and facial affect recognition. The Journal of Nervous and Mental Disease. 195: 758-64. PMID 17984776 DOI: 10.1097/Nmd.0B013E318142Cc31  0.354
2007 Jungerius BJ, Hoogendoorn ML, Bakker SC, Van't Slot R, Bardoel AF, Ophoff RA, Wijmenga C, Kahn RS, Sinke RJ. An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Molecular Psychiatry. 13: 1060-8. PMID 17893707 DOI: 10.1038/Sj.Mp.4002080  0.334
2007 Hoekert M, Kahn RS, Pijnenborg M, Aleman A. Impaired recognition and expression of emotional prosody in schizophrenia: review and meta-analysis. Schizophrenia Research. 96: 135-45. PMID 17766089 DOI: 10.1016/J.Schres.2007.07.023  0.333
2007 Raemaekers M, Vink M, Zandbelt B, van Wezel RJ, Kahn RS, Ramsey NF. Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage. 36: 532-42. PMID 17499525 DOI: 10.1016/J.Neuroimage.2007.03.061  0.773
2007 Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology. 193: 403-14. PMID 17476480 DOI: 10.1007/S00213-007-0792-1  0.647
2007 Peper JS, Brouwer RM, Boomsma DI, Kahn RS, Hulshoff Pol HE. Genetic influences on human brain structure: a review of brain imaging studies in twins. Human Brain Mapping. 28: 464-73. PMID 17415783 DOI: 10.1002/Hbm.20398  0.321
2007 Bakker SC, Hoogendoorn ML, Hendriks J, Verzijlbergen K, Caron S, Verduijn W, Selten JP, Pearson PL, Kahn RS, Sinke RJ. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes, Brain, and Behavior. 6: 113-9. PMID 17410640 DOI: 10.1111/J.1601-183X.2006.00234.X  0.38
2007 Boos HB, Aleman A, Cahn W, Hulshoff Pol H, Kahn RS. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Archives of General Psychiatry. 64: 297-304. PMID 17339518 DOI: 10.1001/Archpsyc.64.3.297  0.402
2007 van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Mandl RC, Collins DL, Evans AC, Kahn RS. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2057-66. PMID 17327887 DOI: 10.1038/Sj.Npp.1301347  0.399
2007 van 't Wout M, Aleman A, Kessels RP, Cahn W, de Haan EH, Kahn RS. Exploring the nature of facial affect processing deficits in schizophrenia. Psychiatry Research. 150: 227-35. PMID 17313979 DOI: 10.1016/J.Psychres.2006.03.010  0.365
2007 van 't Wout M, Aleman A, Bermond B, Kahn RS. No words for feelings: alexithymia in schizophrenia patients and first-degree relatives. Comprehensive Psychiatry. 48: 27-33. PMID 17145278 DOI: 10.1016/J.Comppsych.2006.07.003  0.396
2007 Jager G, Van Hell HH, De Win MM, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 289-97. PMID 17137758 DOI: 10.1016/J.Euroneuro.2006.10.003  0.647
2007 van der Wee NJ, Ramsey NF, van Megen HJ, Denys D, Westenberg HG, Kahn RS. Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 16-23. PMID 16797166 DOI: 10.1016/J.Euroneuro.2006.04.012  0.753
2007 van Hell H, Jager G, Vink M, Ossewaarde L, Kahn R, Ramsey N. P.6.d.005 Differential effects of cannabis and nicotine on the human reward system European Neuropsychopharmacology. 17: S554. DOI: 10.1016/S0924-977X(07)70860-X  0.664
2006 Hulshoff Pol HE, Schnack HG, Posthuma D, Mandl RC, Baaré WF, van Oel C, van Haren NE, Collins DL, Evans AC, Amunts K, Bürgel U, Zilles K, de Geus E, Boomsma DI, Kahn RS. Genetic contributions to human brain morphology and intelligence. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10235-42. PMID 17021179 DOI: 10.1523/Jneurosci.1312-06.2006  0.309
2006 Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS, McEvoy JP, Perkins DO, Rothschild AJ, Sharma T, Tohen MF, Woolson S, Zipursky RB. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophrenia Research. 86: 234-43. PMID 16887334 DOI: 10.1016/J.Schres.2006.06.021  0.359
2006 Raemaekers M, Vink M, van den Heuvel MP, Kahn RS, Ramsey NF. Effects of aging on BOLD fMRI during prosaccades and antisaccades. Journal of Cognitive Neuroscience. 18: 594-603. PMID 16768362 DOI: 10.1162/Jocn.2006.18.4.594  0.713
2006 van der Wee NJ, Hardeman HH, Ramsey NF, Raemaekers M, Van Megen HJ, Denys DA, Westenberg HG, Kahn RS. Saccadic abnormalities in psychotropic-naive obsessive-compulsive disorder without co-morbidity. Psychological Medicine. 36: 1321-6. PMID 16734943 DOI: 10.1017/S0033291706007926  0.74
2006 Scholten MR, van Honk J, Aleman A, Kahn RS. Behavioral inhibition system (BIS), behavioral activation system (BAS) and schizophrenia: relationship with psychopathology and physiology. Journal of Psychiatric Research. 40: 638-45. PMID 16643947 DOI: 10.1016/J.Jpsychires.2006.03.005  0.378
2006 Vink M, Ramsey NF, Raemaekers M, Kahn RS. Striatal dysfunction in schizophrenia and unaffected relatives. Biological Psychiatry. 60: 32-9. PMID 16603134 DOI: 10.1016/J.Biopsych.2005.11.026  0.763
2006 Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, Green AI, Glick IB, Kahn RS, Sharma T, Tohen M, McEvoy JP, Weiden PJ, Lieberman JA. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophrenia Research. 83: 53-63. PMID 16529910 DOI: 10.1016/J.Schres.2005.10.016  0.31
2006 Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology. 185: 358-68. PMID 16521034 DOI: 10.1007/s00213-005-0298-7  0.615
2006 Hulshoff Pol HE, Schnack HG, Mandl RC, Brans RG, van Haren NE, Baaré WF, van Oel CJ, Collins DL, Evans AC, Kahn RS. Gray and white matter density changes in monozygotic and same-sex dizygotic twins discordant for schizophrenia using voxel-based morphometry. Neuroimage. 31: 482-8. PMID 16497519 DOI: 10.1016/J.Neuroimage.2005.12.056  0.396
2006 Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention. Journal of Psychopharmacology (Oxford, England). 20: 789-98. PMID 16478755 DOI: 10.1177/0269881106061712  0.614
2006 Sommer IE, Oranje B, Ramsey NF, Klerk FA, Mandl RC, Westenberg HG, Kahn RS. The influence of amphetamine on language activation: an fMRI study. Psychopharmacology. 183: 387-93. PMID 16284750 DOI: 10.1007/S00213-005-0176-3  0.652
2006 Raemaekers M, Ramsey NF, Vink M, van den Heuvel MP, Kahn RS. Brain activation during antisaccades in unaffected relatives of schizophrenic patients. Biological Psychiatry. 59: 530-5. PMID 16165103 DOI: 10.1016/J.Biopsych.2005.07.030  0.768
2006 Rijsdijk FV, van Haren NE, Picchioni MM, McDonald C, Toulopoulou T, Hulshoff Pol HE, Kahn RS, Murray R, Sham PC. Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychological Medicine. 35: 1399-409. PMID 16164764 DOI: 10.1017/S0033291705005167  0.392
2006 Jager G, de Win M, van der Tweel I, Kahn R, van Ree J, van den Brink W, Ramsey N. Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy users European Neuropsychopharmacology. 16: S80-S81. DOI: 10.1016/S0924-977X(06)80095-7  0.469
2006 van Rijn S, Swaab H, Aleman A, Jellema T, Kahn R. Abnormal social cognitive processing in 47, XXY men: implications for the study of schizophrenia European Neuropsychopharmacology. 16: S54-S55. DOI: 10.1016/S0924-977X(06)80066-0  0.339
2006 Baas D, Aleman A, Ramsey N, De Haan E, Kahn R. P.1.e.027 Imaging neural interactions during social information processing in schizophrenia European Neuropsychopharmacology. 16: S274. DOI: 10.1016/S0924-977X(06)70262-0  0.532
2006 Jager G, De Win M, Kahn R, Van Ree J, Van den Brink W, Ramsey N. S.07.06 Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy users European Neuropsychopharmacology. 16: S176-S177. DOI: 10.1016/S0924-977X(06)70049-9  0.4
2005 Aleman A, Kahn RS. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Progress in Neurobiology. 77: 283-98. PMID 16352388 DOI: 10.1016/J.Pneurobio.2005.11.005  0.351
2005 Scholten MR, Aleman A, Montagne B, Kahn RS. Schizophrenia and processing of facial emotions: sex matters. Schizophrenia Research. 78: 61-7. PMID 16084696 DOI: 10.1016/J.Schres.2005.06.019  0.342
2005 Fleischhacker WW, Keet IPM, Kahn RS, Hummer M, Peuskens J, Hranov LG, Libiger J, Dollfus S, Gaebel W, Davidson M, Galderisi S, Boter H, Rybakowski J, Gheorghe M, Ibor JJL, et al. The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial Schizophrenia Research. 78: 147-156. PMID 16055308 DOI: 10.1016/J.Schres.2005.06.004  0.384
2005 Vink M, Ramsey NF, Raemaekers M, Kahn RS. Negative priming in schizophrenia revisited. Schizophrenia Research. 79: 211-6. PMID 15978779 DOI: 10.1016/J.Schres.2005.05.004  0.743
2005 Raemaekers M, Vink M, van den Heuvel MP, Kahn RS, Ramsey NF. Brain activation related to retrosaccades in saccade experiments. Neuroreport. 16: 1043-7. PMID 15973145 DOI: 10.1097/00001756-200507130-00003  0.708
2005 de Krom M, Bakker SC, Hendriks J, van Elburg A, Hoogendoorn M, Verduijn W, Sinke R, Kahn R, Adan RA. Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients. Psychiatric Genetics. 15: 81. PMID 15900221 DOI: 10.1097/00041444-200506000-00003  0.368
2005 Vink M, Kahn RS, Raemaekers M, van den Heuvel M, Boersma M, Ramsey NF. Function of striatum beyond inhibition and execution of motor responses. Human Brain Mapping. 25: 336-44. PMID 15852388 DOI: 10.1002/Hbm.20111  0.695
2005 Vink M, Kahn RS, Raemaekers M, Ramsey NF. Perceptual bias following visual target selection. Neuroimage. 25: 1168-74. PMID 15850734 DOI: 10.1016/J.Neuroimage.2004.12.042  0.701
2005 Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry. 62: 361-70. PMID 15809403 DOI: 10.1001/Archpsyc.62.4.361  0.391
2005 van der Heijden FM, Tuinier S, Arts NJ, Hoogendoorn ML, Kahn RS, Verhoeven WM. Catatonia: disappeared or under-diagnosed? Psychopathology. 38: 3-8. PMID 15714008 DOI: 10.1159/000083964  0.601
2005 Hoogendoorn ML, Bakker SC, Schnack HG, Selten JP, Otten HG, Verduijn W, van der Heijden FM, Pearson PL, Kahn RS, Sinke RJ. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 134: 6-9. PMID 15635698 DOI: 10.1002/Ajmg.B.30147  0.342
2005 Sitskoorn MM, Ebisch SJ, Appels M, Nuyen J, Kahn RS. Memory profiles in parents of patients with schizophrenia. Psychiatry Research. 128: 27-37. PMID 15450912 DOI: 10.1016/J.Psychres.2004.05.011  0.393
2005 Heijden FMMAvd, Fekkes D, Tuinier S, Sijben AES, Kahn RS, Verhoeven WMA. Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics? Journal of Neural Transmission. 112: 577-585. PMID 15372327 DOI: 10.1007/S00702-004-0200-5  0.332
2004 van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ, Kahn RS, Westenberg HM. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. The American Journal of Psychiatry. 161: 2201-6. PMID 15569890 DOI: 10.1176/Appi.Ajp.161.12.2201  0.569
2004 Sitskoorn MM, Aleman A, Ebisch SJ, Appels MC, Kahn RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophrenia Research. 71: 285-95. PMID 15474899 DOI: 10.1016/J.Schres.2004.03.007  0.389
2004 Haren NEMV, Picchioni MM, Mcdonald C, Marshall N, Davis N, Ribchester T, Pol HEH, Sharma T, Sham P, Kahn RS, Murray RM. A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia Biological Psychiatry. 56: 454-461. PMID 15364044 DOI: 10.1016/J.Biopsych.2004.06.033  0.408
2004 Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating. Journal of Psychopharmacology (Oxford, England). 18: 388-94. PMID 15358983 DOI: 10.1177/026988110401800310  0.593
2004 Bakker SC, Hoogendoorn ML, Selten JP, Verduijn W, Pearson PL, Sinke RJ, Kahn RS. Neuregulin 1: genetic support for schizophrenia subtypes. Molecular Psychiatry. 9: 1061-3. PMID 15303101 DOI: 10.1038/Sj.Mp.4001564  0.409
2004 van der Heijden FM, Tuinier S, Kahn RS, Verhoeven WM. Nonschizophrenic psychotic disorders: the case of cycloid psychoses. Psychopathology. 37: 161-7. PMID 15237245 DOI: 10.1159/000079419  0.545
2004 Perkins DO, Lieberman JA, Gu H, Tohen M, McEvoy J, Green AI, Zipursky RB, Strakowski SM, Sharma T, Kahn RS, Gur R, Tollefson G. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders British Journal of Psychiatry. 185: 18-24. PMID 15231551 DOI: 10.1192/Bjp.185.1.18  0.367
2004 Schnack HG, van Haren NE, Hulshoff Pol HE, Picchioni M, Weisbrod M, Sauer H, Cannon T, Huttunen M, Murray R, Kahn RS. Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Human Brain Mapping. 22: 312-20. PMID 15202109 DOI: 10.1002/Hbm.20040  0.473
2004 van 't Wout M, Aleman A, Kessels RP, Larøi F, Kahn RS. Emotional processing in a non-clinical psychosis-prone sample. Schizophrenia Research. 68: 271-81. PMID 15099609 DOI: 10.1016/J.Schres.2003.09.006  0.312
2004 Jansma JM, Ramsey NF, van der Wee NJ, Kahn RS. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophrenia Research. 68: 159-71. PMID 15099600 DOI: 10.1016/S0920-9964(03)00127-0  0.723
2004 Hulshoff Pol HE, Schnack HG, Mandl RC, Cahn W, Collins DL, Evans AC, Kahn RS. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage. 21: 27-35. PMID 14741639 DOI: 10.1016/J.Neuroimage.2003.09.026  0.403
2004 Ramsey NF, Jansma JM, Jager G, Van Raalten T, Kahn RS. Neurophysiological factors in human information processing capacity. Brain : a Journal of Neurology. 127: 517-25. PMID 14691061 DOI: 10.1093/Brain/Awh060  0.515
2004 Aleman A, de Haan EHF, Kahn RS. Underconstrained perception or underconstrained theory? Behavioral and Brain Sciences. 27: 787-788. DOI: 10.1017/S0140525X04220180  0.363
2004 Kahn R, van der Schot A, Ramsey N, Vink M, Majdandzic J, Nolen W. S.06.04 Visual processing of (un)masked facial affectin euthymic bipolar patients European Neuropsychopharmacology. 14: S122-S123. DOI: 10.1016/S0924-977X(04)80020-8  0.684
2003 van der Wee NJ, Ramsey NF, Jansma JM, Denys DA, van Megen HJ, Westenberg HM, Kahn RS. Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage. 20: 2271-80. PMID 14683728 DOI: 10.1016/J.Neuroimage.2003.05.001  0.696
2003 Aleman A, Böcker KB, Hijman R, de Haan EH, Kahn RS. Cognitive basis of hallucinations in schizophrenia: role of top-down information processing. Schizophrenia Research. 64: 175-85. PMID 14613682 DOI: 10.1016/S0920-9964(03)00060-4  0.355
2003 Kromkamp M, Uylings HB, Smidt MP, Hellemons AJ, Burbach JP, Kahn RS. Decreased thalamic expression of the homeobox gene DLX1 in psychosis. Archives of General Psychiatry. 60: 869-74. PMID 12963668 DOI: 10.1001/Archpsyc.60.9.869  0.386
2003 Appels MC, Sitskoorn MM, Westers P, Lems E, Kahn RS. Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients. Schizophrenia Research. 63: 285-93. PMID 12957707 DOI: 10.1016/S0920-9964(02)00342-0  0.352
2003 Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. The American Journal of Psychiatry. 160: 1396-404. PMID 12900300 DOI: 10.1176/Appi.Ajp.160.8.1396  0.358
2003 Selten JP, Cantor-Graae E, Nahon D, Levav I, Aleman A, Kahn RS. No relationship between risk of schizophrenia and prenatal exposure to stress during the Six-Day War or Yom Kippur War in Israel. Schizophrenia Research. 63: 131-5. PMID 12892867 DOI: 10.1016/S0920-9964(02)00375-4  0.327
2003 Terpstra J, Gispen-De Wied CC, Broekhoven MH, Frankhuijzen AC, Kahn RS, van Ree JM, Wiegant VM. Attenuated stress responsiveness in an animal model for neurodevelopmental psychopathological disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 249-56. PMID 12888184 DOI: 10.1016/S0924-977X(03)00010-5  0.545
2003 Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry. 60: 565-71. PMID 12796219 DOI: 10.1001/Archpsyc.60.6.565  0.332
2003 Posthuma D, Baaré WF, Hulshoff Pol HE, Kahn RS, Boomsma DI, De Geus EJ. Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Research : the Official Journal of the International Society For Twin Studies. 6: 131-9. PMID 12723999 DOI: 10.1375/136905203321536254  0.304
2003 Sommer IE, Ramsey NF, Mandl RC, Kahn RS. Language lateralization in female patients with schizophrenia: an fMRI study. Schizophrenia Research. 60: 183-90. PMID 12591582 DOI: 10.1016/S0920-9964(02)00300-6  0.552
2003 Kahn R, Lieberman J, Charles C, Sharma T, Zipursky R, Gur R, Tohen M, Green A, McEvoy J, Perkins D, Hamer R, Nemeroff C, Rothschild A, Kuldau J, Strakowski S, et al. P.2.131 Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia European Neuropsychopharmacology. 13: S337. DOI: 10.1016/S0924-977X(03)92084-0  0.386
2003 Tuinier S, Fekkes D, Sijben A, Kahn R, Verhoeven W. Atypical antipsychotics : Glutamate, amino acids and monoaminergic parameters European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91969-9  0.526
2003 Sharma T, Lieberman J, McEvoy J, Perkins D, Hamer R, Zipursky R, Kahn R, Gur R, Centorrino F, Glick I, Green A, Nemeroff C, Rothschild A, Strakowski S, Tohen M, et al. S.14.05 Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia European Neuropsychopharmacology. 13: S134-S135. DOI: 10.1016/S0924-977X(03)91655-5  0.32
2003 van Raalten T, Ramsey N, Jansma J, Jager G, Kahn R. Automatization and information processing capacity in schizophrenia Schizophrenia Research. 60: 236. DOI: 10.1016/S0920-9964(03)81232-X  0.551
2003 Cahn W, Pol HH, Schnack H, Mandl R, Collins D, Evans A, Kahn R. Progressive focal gray matter density changes in speech related areas in schizophrenia Schizophrenia Research. 60: 191. DOI: 10.1016/S0920-9964(03)81101-5  0.356
2003 Aleman A, Bocker K, Hijman R, De Haan E, Kahn R. Cognitive basis of hallucinations in schizophrenia: Role of top-down processing Schizophrenia Research. 60: 163. DOI: 10.1016/S0920-9964(03)81016-2  0.352
2003 Sitskoorn M, Aleman A, Ebisch S, Appels M, Kahn R. Meta-analysis of neurocognitive deficits in relatives of patients with schizophrenia: Evidence for a strong cognitive endophenotypic marker Schizophrenia Research. 60: 90. DOI: 10.1016/S0920-9964(03)80655-2  0.372
2003 Lieberman J, Charles HC, Sharma T, Zipursky R, Kahn R, Gur R, Tohen M, Green AI, McEvoy J, Perkins D, Hamer RM, Nemeroff C, Rothschild A, Kuldau J, Strakowski S, et al. Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia Schizophrenia Research. 60: 293. DOI: 10.1016/S0920-9964(03)80491-7  0.39
2003 McEvoy J, Lieberman J, Perkins D, Hamer R, Sharma T, Zipursky R, Kahn R, Gur R, Centorrino F, Glick I, Green A, Nemeroff C, Rothschild A, Strakowski S, Tohen M, et al. Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia Schizophrenia Research. 60: 313. DOI: 10.1016/S0920-9964(03)80257-8  0.321
2003 Ramsey N, Jansma M, Kahn R. Functionele mri en informatieverwerkingsstoornissen bij schizofrenie Neuropraxis. 7: 172-178. DOI: 10.1007/Bf03071069  0.475
2002 Sommer IE, Ramsey NF, Mandl RC, Kahn RS. Language lateralization in monozygotic twin pairs concordant and discordant for handedness. Brain : a Journal of Neurology. 125: 2710-8. PMID 12429598 DOI: 10.1093/Brain/Awf284  0.469
2002 Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry. 59: 1002-10. PMID 12418933 DOI: 10.1001/Archpsyc.59.11.1002  0.403
2002 Cahn W, Hulshoff Pol HE, Bongers M, Schnack HG, Mandl RC, Van Haren NE, Durston S, Koning H, Van Der Linden JA, Kahn RS. Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. The British Journal of Psychiatry. Supplement. 43: s66-72. PMID 12271803 DOI: 10.1192/Bjp.181.43.S66  0.393
2002 Aleman A, de Haan EH, Böcker KB, Hijman R, Kahn RS. Hallucinations in schizophrenia: imbalance between imagery and perception? Schizophrenia Research. 57: 315-6. PMID 12223265 DOI: 10.1016/S0920-9964(01)00291-2  0.377
2002 Ramsey NF, Koning HA, Welles P, Cahn W, van der Linden JA, Kahn RS. Excessive recruitment of neural systems subserving logical reasoning in schizophrenia. Brain : a Journal of Neurology. 125: 1793-807. PMID 12135970 DOI: 10.1093/Brain/Awf188  0.569
2002 Aleman A, Schutter DJ, Ramsey NF, van Honk J, Kessels RP, Hoogduin JM, Postma A, Kahn RS, de Haan EH. Functional anatomy of top-down visuospatial processing in the human brain: evidence from rTMS. Brain Research. Cognitive Brain Research. 14: 300-2. PMID 12067703 DOI: 10.1016/S0926-6410(02)00109-X  0.517
2002 Scheepers FE, Gispen-De Wied CC, Westenberg HG, Kahn RS. Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia. Journal of Clinical Psychopharmacology. 22: 333-4. PMID 12006906 DOI: 10.1097/00004714-200206000-00016  0.609
2002 Aleman A, de Haan EH, Kahn RS. Insight and neurocognitive function in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 241-2. PMID 11983805 DOI: 10.1176/Jnp.14.2.241  0.384
2002 Sitskoorn MM, Nuyen J, Appels MC, van der Wee NJ, Kahn RS. Release from proactive inhibition in schizophrenia and its potential as a genotypic marker. Journal of Clinical and Experimental Neuropsychology. 24: 67-81. PMID 11935425 DOI: 10.1076/Jcen.24.1.67.971  0.635
2002 Raemaekers M, Jansma JM, Cahn W, Van der Geest JN, van der Linden JA, Kahn RS, Ramsey NF. Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3-dimensional event-related functional magnetic resonance imaging. Archives of General Psychiatry. 59: 313-20. PMID 11926931 DOI: 10.1001/Archpsyc.59.4.313  0.585
2002 d'Alfonso AA, Aleman A, Kessels RP, Schouten EA, Postma A, van Der Linden JA, Cahn W, Greene Y, de Haan EH, Kahn RS. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 77-9. PMID 11884659 DOI: 10.1176/Jnp.14.1.77  0.322
2002 Hulshoff Pol HE, Posthuma D, Baaré WF, De Geus EJ, Schnack HG, van Haren NE, van Oel CJ, Kahn RS, Boomsma DI. Twin-singleton differences in brain structure using structural equation modelling. Brain : a Journal of Neurology. 125: 384-90. PMID 11844738 DOI: 10.1093/Brain/Awf035  0.3
2002 Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG, Baaré WF, Kahn RS. Volume changes in gray matter in patients with schizophrenia. The American Journal of Psychiatry. 159: 244-50. PMID 11823266 DOI: 10.1176/Appi.Ajp.159.2.244  0.695
2002 Aleman A, Kahn RS. Top-down modulation, emotion, and hallucination Behavioral and Brain Sciences. 25: 578-578. DOI: 10.1017/S0140525X02220105  0.317
2002 Sommer I, Ramsey N, Graafmans D, Mandl R, Kahn R. How identical are monozygotic twins? An fMRI study on language lateralization European Psychiatry. 17: 11. DOI: 10.1016/S0924-9338(02)80047-5  0.466
2001 Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL, Evans AC, Kahn RS. Focal gray matter density changes in schizophrenia. Archives of General Psychiatry. 58: 1118-25. PMID 11735840 DOI: 10.1001/Archpsyc.58.12.1118  0.376
2001 van Oel CJ, Baaré WF, Hulshoff Pol HE, Haag J, Balazs J, Dingemans A, Kahn RS, Sitskoorn MM. Differentiating between low and high susceptibility to schizophrenia in twins: the significance of dermatoglyphic indices in relation to other determinants of brain development. Schizophrenia Research. 52: 181-93. PMID 11705712 DOI: 10.1016/S0920-9964(01)00153-0  0.421
2001 Sommer IE, Ramsey NF, Kahn RS. Language lateralization in schizophrenia, an fMRI study. Schizophrenia Research. 52: 57-67. PMID 11595392 DOI: 10.1016/S0920-9964(00)00180-8  0.539
2001 Jansma JM, Ramsey NF, Slagter HA, Kahn RS. Functional anatomical correlates of controlled and automatic processing. Journal of Cognitive Neuroscience. 13: 730-43. PMID 11564318 DOI: 10.1162/08989290152541403  0.529
2001 Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 468-75. PMID 11557160 DOI: 10.1016/S0893-133X(01)00250-0  0.585
2001 Baaré WF, Hulshoff Pol HE, Boomsma DI, Posthuma D, de Geus EJ, Schnack HG, van Haren NE, van Oel CJ, Kahn RS. Quantitative genetic modeling of variation in human brain morphology. Cerebral Cortex (New York, N.Y. : 1991). 11: 816-24. PMID 11532887 DOI: 10.1093/Cercor/11.9.816  0.306
2001 Aleman A, Kahn RS. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 11: 289-93. PMID 11532383 DOI: 10.1016/S0924-977X(01)00097-9  0.366
2001 Staal WG, Hulshoff Pol HE, Schnack HG, van Haren NE, Seifert N, Kahn RS. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. The American Journal of Psychiatry. 158: 1140-2. PMID 11431237 DOI: 10.1176/Appi.Ajp.158.7.1140  0.677
2001 Ramsey NF, Sommer IE, Rutten GJ, Kahn RS. Combined analysis of language tasks in fMRI improves assessment of hemispheric dominance for language functions in individual subjects. Neuroimage. 13: 719-33. PMID 11305899 DOI: 10.1006/Nimg.2000.0722  0.501
2001 Selten JP, Veen N, Feller W, Blom JD, Schols D, Camoenië W, Oolders J, van der Velden M, Hoek HW, Rivero VM, van der Graaf Y, Kahn R. Incidence of psychotic disorders in immigrant groups to The Netherlands. The British Journal of Psychiatry : the Journal of Mental Science. 178: 367-72. PMID 11282817 DOI: 10.1192/Bjp.178.4.367  0.321
2001 Sommer I, Ramsey N, Kahn R, Aleman A, Bouma A. Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. 178: 344-51. PMID 11282814 DOI: 10.1192/Bjp.178.4.344  0.57
2001 Schnack HG, Pol HEH, Baaré WFC, Staal WG, Viergever MA, Kahn RS. Automated separation of gray and white matter from MR images of the human brain. Neuroimage. 13: 230-237. PMID 11133325 DOI: 10.1006/Nimg.2000.0669  0.615
2001 Scheepers FE, de Wied CC, Hulshoff Pol HE, van de Flier W, van der Linden JA, Kahn RS. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 47-54. PMID 11106875 DOI: 10.1016/S0893-133X(00)00172-X  0.342
2001 Wee NVd, Jansma M, Megen Hv, Westenberg H, Kahn RS, Ramsey N. Reduced efficacy of the spatial working memory system in obsessive compulsive disorder Neuroimage. 13: 1109. DOI: 10.1016/S1053-8119(01)92436-X  0.481
2001 Ramsey N, van Atteveldt N, Cahn W, Kahn R. Top-down attentional modulation of primary auditory cortex in schizophrenia Neuroimage. 13: 1092. DOI: 10.1016/S1053-8119(01)92420-6  0.544
2001 Raemaekers M, Jansma J, Cahn W, Van der Geest J, Van der Linden J, Kahn R, Ramsey N. Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3D event related fMRI Neuroimage. 13: 1091. DOI: 10.1016/S1053-8119(01)92419-X  0.547
2001 Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins L, Evans AC, Kahn RS. Focal brain abnormalities in schizophrenia detected by linear regression analysis of magnetic resonance gray matter density maps Neuroimage. 13: 1060. DOI: 10.1016/S1053-8119(01)92391-2  0.345
2001 Sommer I, Ramsey N, Graafmans D, Mandl R, Bouma A, Kahn R. Mirror-imaged language activation patterns in healthy monozygotic twins. Neuroimage. 13: 607. DOI: 10.1016/S1053-8119(01)91950-0  0.474
2000 Posthuma D, de Geus EJ, Neale MC, Hulshoff Pol HE, Baaré WEC, Kahn RS, Boomsma D. Multivariate genetic analysis of brain structure in an extended twin design. Behavior Genetics. 30: 311-9. PMID 11206086 DOI: 10.1023/A:1026501501434  0.303
2000 Jansma JM, Ramsey NF, Coppola R, Kahn RS. Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage. 12: 688-97. PMID 11112400 DOI: 10.1006/Nimg.2000.0645  0.518
2000 Pol HEH, Van Der Flier WM, Schnack HG, Tulleken CAF, Ramos LM, Van Ree JM, Kahn RS. Frontal lobe damage and thalamic volume changes Neuroreport. 11: 3039-3041. PMID 11006990 DOI: 10.1097/00001756-200009110-00042  0.54
2000 Staal WG, Hijman R, Hulshoff Pol HE, Kahn RS. Neuropsychological dysfunctions in siblings discordant for schizophrenia. Psychiatry Research. 95: 227-35. PMID 10974361 DOI: 10.1016/S0165-1781(00)00172-4  0.679
2000 Hulshoff Pol HE, Hoek HW, Susser E, Brown AS, Dingemans A, Schnack HG, van Haren NE, Pereira Ramos LM, Gispen-de Wied CC, Kahn RS. Prenatal exposure to famine and brain morphology in schizophrenia. The American Journal of Psychiatry. 157: 1170-2. PMID 10873931 DOI: 10.1016/S0920-9964(00)90321-9  0.381
2000 Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn ML, Jellema K, Kahn RS. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. The American Journal of Psychiatry. 157: 416-21. PMID 10698818 DOI: 10.1176/appi.ajp.157.3.416  0.665
2000 Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. The effects of a sub-anaesthetic dose of ketamine on human selective attention Neuropsychopharmacology. 22: 293-302. PMID 10693157 DOI: 10.1016/S0893-133X(99)00118-9  0.569
2000 Mandl R, Jansma J, Ramsey N, Collins D, Slagter H, Kahn R. On the validity of associating stereotactic coordinates with anatomical nomenclature Neuroimage. 11: S539. DOI: 10.1016/S1053-8119(00)91470-8  0.463
2000 Ramsey N, Sommer I, Kahn R. Combining language tasks in fMRI analysis improves reliability of the derived laterality index Neuroimage. 11: S318. DOI: 10.1016/S1053-8119(00)91250-3  0.472
2000 Jansma M, Ramsey N, Kahn R. Cognitive load and brain activity in patients with schizophrenia Neuroimage. 11: S88. DOI: 10.1016/S1053-8119(00)91021-8  0.565
2000 Sommer IE, Ramsey NF, Kahn RS. Positive symptoms in schizophrenia are associated with decreased lateralization on functional MRI Schizophrenia Research. 41: 159-160. DOI: 10.1016/S0920-9964(00)90686-8  0.559
2000 Jansma J, Ramsey N, Kahn R. Brain correlates of ineffective shifting between controlled and automatic processing in schizophrenia Schizophrenia Research. 41: 135. DOI: 10.1016/S0920-9964(00)90628-5  0.578
2000 Ramsey N, Welles P, Kahn R. Reduced efficiency of brain systems subserving deductive reasoning in medication-naive schizophrenic patients Schizophrenia Research. 41: 135. DOI: 10.1016/S0920-9964(00)90627-3  0.438
2000 Staal W, Hulshoff Pol H, Schnack H, Kahn R. Structural brain abnormalities in schizophrenia in relation to outcome Schizophrenia Research. 41: 122. DOI: 10.1016/S0920-9964(00)90596-6  0.677
1999 Sommer IE, Ramsey NF, Bouma A, Kahn RS. Cerebral mirror-imaging in a monozygotic twin. Lancet. 354: 1445-6. PMID 10543677 DOI: 10.1016/S0140-6736(99)04130-6  0.488
1999 Aleman A, Hijman R, de Haan EH, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. The American Journal of Psychiatry. 156: 1358-66. PMID 10484945 DOI: 10.1176/Ajp.156.9.1358  0.342
1999 Selten JP, Brown AS, Moons KG, Slaets JP, Susser ES, Kahn RS. Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands. Schizophrenia Research. 38: 85-91. PMID 10463456 DOI: 10.1016/S0920-9964(99)00005-5  0.335
1999 Van Berckel BNM, Evenblij CN, Van Loon BJAM, Maas MF, Van Der Geld MAM, Wynne HJ, Van Ree JM, Kahn RS. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: A double-blind, parallel, placebo-controlled study Neuropsychopharmacology. 21: 203-210. PMID 10432468 DOI: 10.1016/S0893-133X(99)00014-7  0.565
1999 Staal WG, Hulshoff Pol HE, Kahn RS. Outcome of schizophrenia in relation to brain abnormalities. Schizophrenia Bulletin. 25: 337-48. PMID 10416735 DOI: 10.1093/Oxfordjournals.Schbul.A033382  0.661
1999 Baaré WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS. Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biological Psychiatry. 45: 1597-605. PMID 10376121 DOI: 10.1016/S0006-3223(98)00266-2  0.375
1999 Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. P50 suppression and prepulse inhibition of the startle reflex in humans: A correlational study Biological Psychiatry. 45: 883-890. PMID 10202576 DOI: 10.1016/S0006-3223(98)00128-0  0.542
1999 van der Wee N, Ramsey N, Jansma J, van Megen H, Westenberg H, Kahn R. Spatial working memory in obsessive compulsive disorder: A three-dimensional functional magnetic resonance imaging study European Neuropsychopharmacology. 9: 309. DOI: 10.1016/S0924-977X(99)80404-0  0.492
1998 Staal WG, Hulshoff Pol HE, Schnack H, van der Schot AC, Kahn RS. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. The American Journal of Psychiatry. 155: 1784-6. PMID 9842796 DOI: 10.1176/Ajp.155.12.1784  0.701
1998 Jansen LM, Gispen-de Wied CC, Gademan PJ, De Jonge RC, van der Linden JA, Kahn RS. Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophrenia Research. 33: 87-94. PMID 9783348 DOI: 10.1016/S0920-9964(98)00066-8  0.347
1998 Ramsey NF, van den Brink JS, van Muiswinkel AM, Folkers PJ, Moonen CT, Jansma JM, Kahn RS. Phase navigator correction in 3D fMRI improves detection of brain activation: quantitative assessment with a graded motor activation procedure. Neuroimage. 8: 240-8. PMID 9758738 DOI: 10.1006/Nimg.1998.0358  0.517
1998 Van Berckel BNM, Lipsch C, Gispen-de Wied C, Wynne HJ, Blankenstein MA, Van Ree JM, Kahn RS. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers Psychopharmacology. 138: 190-197. PMID 9718289 DOI: 10.1007/S002130050662  0.513
1998 Van Berckel BNM, Oranje B, Van Ree JM, Verbaten MN, Kahn RS. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects Psychopharmacology. 137: 271-281. PMID 9683005 DOI: 10.1007/S002130050620  0.536
1998 Ramsey N, Koning H, Kahn R. 3D fMRI of functions involved in setshifting Neuroimage. 7: S889. DOI: 10.1016/S1053-8119(18)31722-1  0.476
1998 Jansma J, Ramsey N, Kahn R. Experimental design for separation of two simultaneously administered stimulation protocols Neuroimage. 7: S561. DOI: 10.1016/S1053-8119(18)31394-6  0.444
1998 Staal W, Pol H, Schnack H, van der Schot A, Kahn R. Thalamic and ventricular volumes in siblings discordant for schizophrenia and normal controls European Neuropsychopharmacology. 8: S217-S218. DOI: 10.1016/S0924-977X(98)80353-2  0.682
1998 Hulshoff Pol H, Staal W, Baaré W, Schnack H, Kahn R. Genetic risk to develop schizophrenia and volume decrease of the thalamus European Neuropsychopharmacology. 8: S94-S95. DOI: 10.1016/S0924-977X(98)80067-9  0.669
1998 Staal W, HulshoffPol H, Schnack H, van der Schot A, Gispen- de Wied C, Hijman R, Kahn R. Thalamic volumes in patients with schizophrenia, healthy siblings and normal controls Schizophrenia Research. 29: 139-140. DOI: 10.1016/S0920-9964(97)88655-0  0.693
1998 Jansma J, Ramsey N, van der Linden J, Kahn R. Schizophrenic patients exhibit increased sensorimotor cortex activation with equal performance level Schizophrenia Research. 29: 114. DOI: 10.1016/S0920-9964(97)88588-X  0.516
1998 Ramsey N, Jansma J, Cahn W, Mali W, Kahn R. Motion-corrected 3D fmri assessment of visual cortex: Schizophrenic patients show the same regional response to photic stimulation as controls Schizophrenia Research. 29: 112. DOI: 10.1016/S0920-9964(97)88584-2  0.501
1997 Van Berckel BNM, Lipsch C, Timp S, Wied CGd, Wynne H, Van Ree JM, Kahn RS. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects Neuropsychopharmacology. 16: 317-324. PMID 9109102 DOI: 10.1016/S0893-133X(96)00196-0  0.449
1997 Schnack HG, Hulshoff Pol HE, Staal W, Vincke K, Niessen WM, Viergeve MA, Kahn RS. Application of a nearly automatic image scale space linking scheme to segment gray and white matter and intracranial volumes on MR images Schizophrenia Research. 24: 155. DOI: 10.1016/S0920-9964(97)82445-0  0.595
1996 van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients. Biological Psychiatry. 40: 1298-300. PMID 8959296 DOI: 10.1016/S0006-3223(96)00311-3  0.651
1996 Megen HJGMv, Westenberg HGM, Boer JAD, Kahn R. The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder. European Neuropsychopharmacology. 6: 187-194. PMID 8880078 DOI: 10.1016/0924-977X(96)00018-1  0.3
1996 Kalkman J, Hoek H, Susser E, Kahn R. Case-control and neuro-imaging study in persons with schizophrenia after prenatal exposure to the Dutch Famine in 1945 European Neuropsychopharmacology. 6: S4-102. DOI: 10.1016/0924-977X(96)83045-8  0.344
1996 Jansma J, Ramsey N, Meinders L, Mali W, Kahn R. Comparison of brain activity patterns during finger opposition with and without tactile stimulation using a BOLD-fMRI method European Neuropsychopharmacology. 6: S4-167. DOI: 10.1016/0924-977X(96)82980-4  0.5
1993 Davidson M, Kahn R, Stern RG, Hirschowitz J, Apter S, Knott P, Davis KL. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia Psychiatry Research-Neuroimaging. 46: 151-163. PMID 8483974 DOI: 10.1016/0165-1781(93)90017-B  0.318
1993 Harvey P, Kahn R, Davidson M. Neuropsychological correlates of central monoamine function in chronic schizophrenia European Neuropsychopharmacology. 3: 401-402. DOI: 10.1016/0924-977X(93)90195-R  0.37
1993 Harvey P, Kahn R, Davidson M, Davis KL. Neuropsychological correlates of central monoamine function in schizophrenia Schizophrenia Research. 9: 177. DOI: 10.1016/0920-9964(93)90348-M  0.382
1992 Kahn RS, van Praag HM. Panic disorder: a biological perspective. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2: 1-20. PMID 1638169 DOI: 10.1016/0924-977X(92)90031-3  0.423
1992 Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects. Psychopharmacology. 106: 388-90. PMID 1533289 DOI: 10.1007/BF02245423  0.434
1992 Asnis GM, Wetzler S, Sanderson WC, Kahn RS, van Praag HM. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Research. 43: 65-76. PMID 1438618 DOI: 10.1016/0165-1781(92)90142-P  0.457
1992 Kahn R, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M. Serotonin function in schizophrenia: Effects of meta- chlorophenylpiperazine in schizophrenia patients and healthy subjects Psychiatry Research-Neuroimaging. 43: 1-12. PMID 1332094 DOI: 10.1016/0165-1781(92)90136-Q  0.357
1992 Kahn RS, Siever L, Knott P, Amin F, Dumont K, Moore C, Davidson M. SEROTONIN DYSFUNCTION IN TREATMENT-REFRACTORY SCHIZOPHRENIA Clinical Neuropharmacology. 15: 168B. DOI: 10.1097/00002826-199202001-00323  0.368
1992 Kahn RS, Davidson M, Knott P, Stern RG, Webster L, Davis KL. EFFECT OF NEUROLEPTIC TREATMENT ON CSF MONOAMINE METABOLITES: RELEVANCE OF 5HT-DA INTERACTIONS IN SCHIZOPHRENIA. Clinical Neuropharmacology. 15: 119B. DOI: 10.1097/00002826-199202001-00230  0.316
1992 Kahn R, Siever L, Knott P, Stern R, Amin F, Dumont K, Apter S, Davidson M. m-chlorophenylpiperazine as a probe of serotonin function in schizophrenia Schizophrenia Research. 6: 138. DOI: 10.1016/0920-9964(92)90199-F  0.354
1992 Kahn R, Davidson M, Knott P, Stern R, Amin F, Webster L, Apter S, Davis K. Effect of haloperidol on CSF monoamine metabolites in schizophrenia. Symptomatic improvement is related to altered dopamine-serotonin interaction Schizophrenia Research. 6: 118. DOI: 10.1016/0920-9964(92)90155-X  0.35
1992 Stern R, Kahn R, Davidson M, Harvey P, Amin F, Apter S, DuMont K, Hirschowitz J, Davis K. Significant decrease in psychopathology within three days of haloperidol treatment in chronic schizophrenia Schizophrenia Research. 6: 109-110. DOI: 10.1016/0920-9964(92)90134-Q  0.348
1991 Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Archives of General Psychiatry. 48: 910-3. PMID 1929760 DOI: 10.1001/Archpsyc.1991.01810340042005  0.305
1991 Wetzler S, Kahn RS, Asnis GM, Korn M, van Praag HM. Serotonin receptor sensitivity and aggression. Psychiatry Research. 37: 271-9. PMID 1891509 DOI: 10.1016/0165-1781(91)90063-U  0.443
1991 Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biological Psychiatry. 30: 770-8. PMID 1751620 DOI: 10.1016/0006-3223(91)90233-C  0.52
1991 Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. The American Journal of Psychiatry. 148: 1474-86. PMID 1681750 DOI: 10.1176/Ajp.148.11.1474  0.374
1991 Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research. 37: 25-34. PMID 1650487 DOI: 10.1016/0165-1781(91)90103-V  0.447
1991 Stern R, Kahn R, Harvey P, Cooper M, Kerman B, Apter S, Davidson M. Evidence for an early antipsychotic effect of neuroleptics in patients with chronic schizophrenia Schizophrenia Research. 4: 294-295. DOI: 10.1016/0920-9964(91)90174-P  0.38
1990 Kahn RS, van Praag HM. Panic disorder: a presynaptic serotonin defect? Psychiatry Research. 31: 209-10. PMID 2326399 DOI: 10.1016/0165-1781(90)90123-M  0.483
1990 Wetzler S, Kahn RS, Cahn W, van Praag HM, Asnis GM. Psychological test characteristics of depressed and panic patients. Psychiatry Research. 31: 179-92. PMID 2326397 DOI: 10.1016/0165-1781(90)90120-T  0.512
1990 Kalus O, Kahn RS, Wetzler S, Asnis GM, van Praag HM. Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks. Biological Psychiatry. 28: 1053-7. PMID 2288999 DOI: 10.1016/0006-3223(90)90606-3  0.422
1990 Van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology. Annals of the New York Academy of Sciences. 600: 501-10. PMID 2252329  0.458
1990 Kahn RS, Kalus O, Wetzler S, Cahn W, Asnis GM, van Praag HM. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Psychiatry Research. 33: 189-98. PMID 2243896 DOI: 10.1016/0165-1781(90)90073-E  0.423
1990 Kahn RS, Wetzler S, Asnis GM, Papolos D, van Praag HM. Serotonin receptor sensitivity in major depression. Biological Psychiatry. 28: 358-62. PMID 2204434 DOI: 10.1016/0006-3223(90)90663-M  0.394
1990 Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology. 100: 339-44. PMID 2156278 DOI: 10.1007/BF02244603  0.426
1990 van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Monoamines and abnormal behaviour. A multi-aminergic perspective. The British Journal of Psychiatry : the Journal of Mental Science. 157: 723-34. PMID 1980627  0.456
1989 Kahn RS, Cahn W, van Praag HM. [Pathogenesis of panic disorders]. Nederlands Tijdschrift Voor Geneeskunde. 133: 498-501. PMID 2651934  0.42
1988 Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G. Serotonin and anxiety revisited. Biological Psychiatry. 23: 189-208. PMID 3275471 DOI: 10.1016/0006-3223(88)90091-1  0.424
1988 Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Research. 25: 101-4. PMID 3217461 DOI: 10.1016/0165-1781(88)90163-1  0.451
1988 van Praag HM, Kahn RS. L-5-hydroxytryptophan in depression and anxiety. Schweizerische Rundschau Fã¼R Medizin Praxis = Revue Suisse De Mã©Decine Praxis. 77: 40-6. PMID 3055148  0.38
1988 Kahn RS, Asnis GM, Wetzler S, van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology. 96: 360-4. PMID 2906153 DOI: 10.1007/BF00216062  0.434
1987 Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. International Clinical Psychopharmacology. 2: 33-45. PMID 3312397 DOI: 10.1097/00004850-198701000-00003  0.656
1987 den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology. 2: 21-32. PMID 3117876 DOI: 10.1097/00004850-198701000-00002  0.65
1987 van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. Journal of Affective Disorders. 13: 1-8. PMID 2959695 DOI: 10.1016/0165-0327(87)90067-X  0.435
1985 Kahn RS, Westenberg HG. L-5-hydroxytryptophan in the treatment of anxiety disorders. Journal of Affective Disorders. 8: 197-200. PMID 3157732 DOI: 10.1016/0165-0327(85)90046-1  0.525
1984 Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4  0.757
1982 Van Ree JM, Innemee H, Louwerens JW, Kahn RS, De Wied D. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine. Neuropharmacology. 21: 1095-101. PMID 6184639 DOI: 10.1016/0028-3908(82)90166-6  0.463
Show low-probability matches.